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Abstract 
Background: There is a bi-directional relationship between Coronary Heart 
Disease (CHD) and depression. In recent years, research has sought to 
understand the role of Repetitive Thought (RT) in the relationship between CHD 
and depression. It has been argued that RT could be a vulnerability factor or a 
perpetuating mechanism linking CHD and depression.  
Objectives: This review summarises and synthesises the literature investigating 
RT and its relationship to depression in CHD populations.   
Method: Systematic review of all literature to date using MEDLINE, PsycINFO, 
and Web of Knowledge databases with a narrative discussion.  
Results: Seven relevant papers were included, consisting of cross-sectional and 
prospective studies.  
Conclusions: There is a small amount of research that supports the notion of RT 
being involved in the relationship between depression and CHD.  However the 
evidence is limited and how RT works as a mechanism or vulnerability factor 
remains unknown.  Appropriate additional research is outlined. 
Keywords: CHD, depression, repetitive thought, rumination.  
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Introduction 
Rationale 
Depression and Coronary Heart Disease (CHD). The ICD-10 defines 
depression to be when an individual experiences low mood, a reduction in 
levels of energy and activity, a reduced capacity for enjoyment or interest, and 
poor concentration (World Health Organisation, 2004). CHD includes angina, 
Acute Coronary Syndrome (ACS), Myocardial Infarction (MI) or heart failure and 
is thought to affect around 2.7 million people in the UK (NHS Choices, 2012).   
CHD and depression have a co-morbid relationship (Goldston & Baillie, 
2008).  Reviews have concluded that depression is an independent risk factor 
for the onset of CHD (Lett et al., 2004), is associated with increased mortality 
(Barth, Schumacher, & Herrmann-Lingen, 2004) and adverse prognosis once 
CHD is established (Frasure-Smith & Lesperance, 2006; Wulsin, 2004).  
Research shows varying rates of depression in CHD populations of between 
10-25% (Rudisch & Nemeroff, 2003; Whooley, 2006).  Depression severity 
varies depending on time since diagnosis; 10% of CHD outpatients have above 
moderate depression (Whooley et al., 2008), compared to 20% post-MI 
(Dickens et al., 2004; Lesperance & Frasure-Smith, 2000; Lett et al., 2004; 
Musselman, Evans, & Nemeroff, 1998). In comparison, the prevalence rate of 
depression in the general population is approximately 2.6% (NICE, 2009).   
CHD, Depression and Repetitive Thought (RT). RT is defined as, “the 
process of thinking attentively, repetitively, or frequently about oneself and 
one’s world” (Segerstrom, Stanton, Alden, & Shortridge, 2003, p. 909).  Watkins 
(2008) reviewed a number of cognitive mechanisms under the heading of RT, 
including: rumination, worry, repetitive thought, perseverative cognition, mental 
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stimulation, emotional processing, cognitive processing, reflection, problem 
solving, defensive pessimism, mind wandering, counterfactual and negative 
thought.  RT includes depressive rumination, and is defined as “behaviors and 
thoughts that focus one's attention on one's depressive symptoms and on the 
implications of these symptoms” (Nolen-Hoeksema, 1991, p. 569). Depressive 
rumination has been identified as a final common mediator for a range of 
depression vulnerabilities including negative beliefs (Spasojević & Alloy, 2001), 
which has been experimentally demonstrated to increase negative thinking and 
cognitive distortions (Lyubomirsky & Nolen-Hoeksema, 1995; Rimes & Watkins, 
2005). Prospective longitudinal research has found rumination predicted 
depression including the onset of new depressive episodes (Nolen-Hoeksema, 
2000).  Considerable evidence has shown that RT is implicated in the onset, 
duration, and maintenance of depression (Nolen-Hoeksema, Wisco, & 
Lyubomirsky, 2008; Segerstrom, Tsao, Alden, & Craske, 2000; Watkins, 2008).   
Relevant theories linking RT and depression.   
There are a number of potential relationships between CHD, depression 
and RT: e.g., (i) RT as common vulnerability factor for depression and CHD, (ii) 
RT as mediator of relationship between CHD and depression; (iii) RT as 
mediator of relationship between depression and CHD; (iv) RT as a moderator 
of relationship between depression and CHD, or (v) no causal relationships, but 
all factors associated with a common marker (e.g., neuroticism). To understand 
the CHD, depression and RT relationship it is important to consider relevant 
supported models which have been developed to understand the relationship 
between RT and depression.   
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Control Theory proposed that discrepancy between an individuals’ 
perceived and desired rate of goal progress can result in rumination; which 
persists until the goal is either resolved or abandoned (Martin & Tesser, 1996).  
Consistent with this, experimental research demonstrated that thinking about 
unresolved goals increased ruminative thoughts relative to thinking about 
resolved goals (Roberts, Watkins, & Wills, 2013).  Control theory would predict 
that RT would be prevalent in CHD as desired goals may suddenly become less 
attainable for individuals, resulting in the experience of multiple losses (e.g. in 
health, lifestyle, perceived mortality) which could increase rumination. 
The response style theory (Nolen-Hoeksema, 1991), proposed that 
depressive rumination was a style of responding to distressing symptoms.  
Individuals repetitively focus on the symptoms of distress and the causes or 
consequences of the distress.  The theory is well supported and evidence has 
shown rumination predicts the onset of depression (Nolen-Hoeksema, Wisco & 
Lyubmirsky, 2008).  The subsequent continued ruminative response is 
hypothesised to prolong depression.  The theory should be applicable in all 
populations, including CHD where it could potentially account for elevated 
depression.   
 Relevant theories and models linking CHD and RT. Initially, Roberts 
(1989) proposed that cognitive mechanisms influence the relationship between 
depression and CHD: following an MI, individuals are hypothesised to 
experience cognitive distortions such as overgeneralisation, where general 
inferences about the self and the future are drawn on the basis of a single event 
(the MI), which, in turn, leads to guilt and depression.  Overgeneralisation is a 
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characteristic of unhelpful abstract RT and a consequence of abstract 
rumination (Watkins, 2008).   
Perseverative cognition is defined as “the repeated or chronic activation 
of the cognitive representation of one or more psychological stressors” 
(Brosschot, Gerin, & Thayer, 2006, p. 2), it is often referred to interchangeably 
with rumination and RT.  Brosschot et al. (2006) argued that perseverative 
cognition takes place before, during, and after a stressful event.  They proposed 
that perseverative cognition about a stressor creates a prolonged stress 
response and this causes sustained activation of physiological systems, 
including cardiovascular systems, which leads to worsened cardiac outcomes.  
Supporting experimental research found perseverative cognition delayed 
cardiac recovery (Verkuil, Brosschot, De Beurs, & Thayer, 2009). However, the 
evidence is limited by few experimental studies investigating the impact of RT 
on cardiac recovery.  Existing studies have been conducted in non-cardiac 
populations and with induced rumination (Glynn, 2002).  Therefore, they do not 
investigate the long-term implications of RT activating physiological systems.  
However, it is hypothesised that because evidence has shown rumination 
affects cardiac recovery, rumination may also be involved in CHD outcomes, 
though presently there is no robust evidence to support this (Kubzansky, 
Davidson, & Rozanski, 2005; Larsen & Christenfeld, 2009).   
Larsen and Christenfeld (2009) extended Brosschot et al.’s (2005) earlier 
model to include depression.  They hypothesised that perseverative cognition 
was related to both CHD and depression. They argued that inflexibility 
(cognitive, emotional, and physiological) leads to rumination, worry, low heart 
rate variability, reduced vagal tone and sympathetic arousal. These factors then 
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perpetuate one another and cause increased physiological arousal, worsening 
cardiac and depression outcomes. The model proposes that rumination could 
be one mechanism that elevates physiological arousal and impacts on CHD and 
depression outcomes.    
 Some reviews have investigated the involvement of cognitive processes 
in depression and CHD.  They have concluded that the relationship between 
CHD and depression involves negative states or negative beliefs (French, 
Cooper & Weinman, 2006).  One review identified five negative states 
(hopelessness, pessimism, rumination, anxiety, and anger) associated with 
depression and CHD (Kubzansky et al., 2005).  Although this review did not 
specifically explore RT, it identified that rumination may well be involved.  
However, no studies involving rumination were conducted within the CHD 
population and due to the brevity of the review the results must be interpreted 
with some caution.  Moreover, this was not a systematic review and is outdated 
following recent developments in the empirical data. This highlights a need for a 
current review to specifically address the relationship between RT, depression, 
and CHD. 
Despite preliminary theoretical and empirical data implicating RT as a 
factor linking CHD and depression, to the knowledge of the researcher, to date, 
there have been no systematic reviews that have specifically examined the role 
of RT as a mechanism or risk factor in the relationship between CHD and 
depression.  This review therefore questions whether there is sufficient 
evidence to support the idea that the relationship between CHD and depression 
could be mediated by the cognitive mechanism of RT. Consolidation of the 
research will inform the field of findings to date, outline inconsistencies in 
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findings, and highlight gaps in knowledge where further research would be 
beneficial.  
Objectives 
This systematic review aims to appraise the relevant literature in order to 
examine the evidence supporting a relationship between RT, CHD and 
depression.  The review will seek to evaluate all literature which refers to RT as 
being involved in CHD and depression.  It is interested in any mechanisms, or 
risk factors involved in the relationship between CHD and depression, and 
those that involve RT or closely related constructs. The review will focus on 
empirical evidence. Studies to be reviewed must be written in English and 
conducted with cardiac populations (CHD patients or following a MI). All studies 
included will be quantitative (cross-sectional, experimental, prospective, 
retrospective and clinical trials).  The search included all empirical evidence 
published prior to April 2014.  The search will not be restricted by interventions 
and comparators. 
Methods 
Eligibility Criteria 
This systematic review was conducted using the PRISMA reporting 
protocol (Moher, Liberati, Tetzlaff, & Altman, 2009) as this allows for a 
standardised non-biased approach to the review.  Population inclusion criteria 
included all studies with CHD and depression in an adult population.  All 
settings such as outpatients, cardiac rehabilitation or inpatients were included.  
Outcome inclusion criteria included: (i) studies that had investigated both CHD 
and depression, (ii) were related to RT as outlined by Watkins (2008) or wider 
cognitive processes that  would specifically include RT, e.g. dysfunctional 
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cognitions, (iii) focused on relationships or processes e.g. mechanisms for RT 
relationship with CHD and depression, (iv) studies with prospective, 
retrospective, experimental, cross-sectional designs, meta-analysis, and clinical 
trials, and (v) all searchable dates.  The exclusion criteria was: (i) discussion 
papers, dissertations, books and media material, (ii) studies not published in 
English, (iii) any studies not conducted using an adult population of over 18 
years, and (iv) any studies that focused on beliefs or general psychological or 
cognitive processes.  
Information Sources and Search Strategy 
In March 2014, MEDLINE, PsycINFO, and Web of Knowledge databases 
were systematically searched for relevant studies and reviews using the 
following string of search terms: [(Coronary heart disease or Myocardial 
infarction) and (risk or mechanisms or vulnerability or factor) and (ruminat* or 
worry or repetitive thought or perseverative cognition or mental stimulation or 
emotional processing or cognitive process or reflection or problem solving or 
defensive pessimism or mind wandering or counterfactual or negative thought) 
and depress*].  The terms used to search for RT were based on terms outlined 
in a previous systematic review (Watkins, 2008). Additionally, surrounding 
literature was revised for backward and forward citations from the selected 
papers to ensure all relevant papers were attained.  
Data Collection Process 
Data was extracted from the databases into EndNote X6 software.  This 
allowed for archiving of articles for a second review to reduce human error and 
bias where possible. At the point of reviewing abstracts and to improve validity, 
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a second reviewer checked 50% of the studies to insure the inclusion and 
exclusion criteria were adhered to.   
Risk of Bias in Studies 
Each article was assessed for risk of bias.  This included publication, 
reporting, selection, and measurement bias. Overall biases of the study such as 
study design, sample population and data collection methods were considered. 
Bias was assessed based on information provided in the study.  Where data 
were available it was checked to ensure authors had indeed reflected the 
findings by reviewing statistical output, ensuring all potential studies were 
included in discussions and confirming that any key conflicting and supporting 
studies had been accurately reported.  Results were checked to ensure they 
had been accurately reflected and reasonable conclusions had been drawn.   
Results 
Study Selection 
Initial searches revealed 659 potentially relevant articles.  After applying 
inclusion and exclusion criteria to the titles, 108 articles remained. Following a 
review of title and abstracts, a further 90 were eliminated as they did not fully 
meet the inclusion criteria.  The majority of papers removed at this stage did not 
specifically focus on any cognitive process or focused on biological 
mechanisms.  At the abstract stage in the search, 50% of the articles were 
additionally reviewed by an independent rater to establish the validity of the 
process. Excellent levels of consistency (100%) were found between the 
researcher and second rater with regard to the excluded or included studies, 
which ensured the validity of this process.  There were potentially 18 papers 
remaining, but following a review of the full text articles, 12 were excluded for 
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not meeting the inclusion criteria.  Some relevant but non-empirical papers were 
excluded, their citations were checked.  Exclusions were made for articles that 
examined cognitive processes that were not closely associated with RT, e.g. 
cognitive factors or those focused on beliefs e.g. illness perceptions.  An 
additional paper was found by reading around the literature and checking 
backward and forward citations.  Seven appropriate empirical papers remained, 
which will be discussed within the review.  Figure 1 below shows a flow diagram 
summarising the study selection. 
Figure 1. Flow diagram of article selection through the different stages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Citations and 
references of remaining 
6 articles were reviewed 
and surrounding 
literature and 1 
additional article was 
added 
7 articles included in 
review  
12 articles were 
removed following full 
text reviews, n= 6 
90 articles excluded 
when abstracts review 
for not fully meeting 
inclusion criteria, n= 18 
n= 659 potentially 
relevant studies 
identified 
551 articles excluded 
for duplicates and not 
meeting inclusion 
criteria, n= 108 
17 
 
 
Synthesis of Results 
Overview of selected articles. Table 1 provides an overview of the 
seven papers included in this review. There were four cross-sectional studies 
and three prospective studies.  This narrative review will discuss the available 
empirical research by type of study; cross-sectional and prospective.    
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Table 1.  
Summary of the seven papers included in the review 
 
Author  Design  Sample Measures 
used 
Main finding 
Cross-sectional studies 
Dickens, 
Coventry, Khara, 
Bower, Mansell, 
and Bakerly 
(2012) 
Cross-
sectional 
190 patient with 
Long Term 
Conditions 
(LTCs) 
PSWQ, 
HADS, 
WBSI, AAQ 
22% of CHD patients were affected with symptoms 
of depression. They found participants with high 
worry, thought suppression and thought avoidance 
were more likely to suffer with depression when 
controlling for confounding variables. 
Doyle, Mcgee, 
Conroy, and 
Delaney (2011b) 
Cross-
sectional 
336 Acute 
Coronary 
Syndrome 
(ACS) patients 
HADS-D 
MQ-10, LTE-
Q, PES-AD, 
BJW-S, 
DS14 
Vulnerabilities (cognitive, behavioural, personality 
D, and interpersonal) associated with depression in 
ACS patients. Psychological vulnerabilities were 
more strongly associated with depression than 
demographic or disease vulnerabilities. 
Garnefski et al. 
(2009) 
Cross-
sectional 
139 people 
following MI 
CERQ, 
GOQ, 
HADS. 
Cognitive coping strategies of rumination and 
catastrophising were significantly associated with 
higher depressive symptoms. Positive refocusing, 
goal re-engagement, were associated with lower 
depressive symptoms. 
Martens et al. 
(2006) 
Cross-
sectional 
matched 
case–
control 
design 
120 (40 post MI 
depressed/ 40 
post MI non-
depressed. 40 
psychiatric 
outpatients) 
Clinical 
interview 
(SCID and 
CIDI), BDI, 
CCL-D 
Depressive cognitions were higher in depressed 
patients post-MI than non-depressed patients post 
MI but not higher than clinically depressed 
psychiatric patients.  
Prospective Studies 
Denton, 
Rieckmann, 
Davidson, and 
Chaplin (2012) 
Prospective 
longitudinal 
387 Acute 
Coronary 
Syndrome 
BDI-I, DAS-
24, PES-E, 
LVEF, RST, 
DAS, RSS 
Rumination independently predicted increased 
depression severity, above other vulnerabilities; it 
also interacted with poor dyadic adjustment to 
worsen severity of depression. 
Doyle, Mcgee, 
Delaney, 
Motterlini, and 
Conroy (2011a) 
Prospective 
longitudinal 
375 Acute 
Coronary 
Syndrome 
(ACS) Patients 
BDI-FS, 
HADS 
(depression 
subscale), 
LTE-Q, PES-
AD, BJW-S, 
DS14 
Identified that one year post ACS that depression 
was predicted by stressful life events, reinforcing 
events, cognitive distortions, personality for 
participants with persistent depression.  For 
participants with sub-threshold depression, 
cognitive distortions and stressful life events were 
predictive of depression. 
Garnefski and 
Kraaji (2010) 
Prospective 
longitudinal 
88 people 
following MI 
CERQ, 
GOQ, and 
HADS. 
After one year post-MI cognitive coping strategies 
(rumination, catastrophising, and positive 
refocusing) and goal adjustment strategies 
predicted 39% of the variance in depressive 
symptoms. Rumination and catastrophising at 
baseline was significantly associated with 
increased depressive symptoms at one year 
follow-up.  Goal related coping at baseline was 
significantly associated with less depressive 
symptoms at one year follow up.   
Abbreviations= CHD (Coronary Heart Disease), HADS (Hospital Anxiety and Depression Scale), BIPQ (Brief Illness 
Perceptions Questionnaire), IPQ (Illness Perceptions Questionnaire), CAQ (Cardiac Anxiety Questionnaire), SCL-90R( 
Symptom Checklist-90, revised version), MOSSAS (Medical Outcomes Study Specific Adherence scale), PCS SF-36 (Physical 
Component Score- Short Form-36, HRQol (Health Related Quality of Life), PSWQ (Penn State Worry Questionnaire), WBSI 
(White Bear Suppression Inventory), AAQ (Acceptance and Action Questionnaire), LTCs (Long-Term Health Condition’s), BDI-
FS (Beck Depression Inventory – Fast Screen), LTE-Q (List of Threatening Experiences Questionnaire), PES-AD (Pleasant 
Events Schedule – Alzheimer’s Disease-short version), PES-E (Pleasant Events Schedule – Ederly) BJW-S (Belief in a Just 
World – Self scale), DS14 (Type D scale), MQ-10 (Maastricht Questionnaire – 10 item), CERQ (Cognitive Emotion Regulation 
Questionnaire), GOQ (Goal Obstruction Questionnaire), PHQ-9 (Patient Health Questionnaire), LVEF (left ventricular ejection 
fraction), BMI (Body mass index), BDI (Beck Depression Inventory),  CCL-D (Beck Cognition Checklist-Depression subscale), 
SCID (Structured Clinical Interview for DSM-IV Axis I disorders), CIDI (Composite International Diagnostic Interview), DAS-24 
(Dysfunctional Attitude Scale), DAS (Dyadic Adjustment Scale), RSS (Ruminative Responses Scale). 
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Cross-sectional Studies.  Overall, the cross-sectional studies show that 
there is a significant positive relationship between RT and constructs closely 
associated with RT (including perseverative cognition, rumination, cognitive 
distortions, depressive cognitions) and depression in CHD populations or post-
MI (Dickens et al., 2012; Doyle et al., 2011b; Garnefski et al., 2009; Martens, 
2006).  The strength and importance of the relationship varies across the 
studies.  Garnefski et al. (2009) investigated the relationship between goal 
adjustment (disengagement and reengagement) and cognitive coping variables 
(rumination/catastrophising, positive refocusing, planning, putting in 
perspective, positive appraisal and other blame) and depression in post-MI 
patients.  They found a highly significant positive correlation between rumination 
and catastrophising and depression post-MI, with rumination having a greater 
effect.  Rumination was significantly more strongly associated with depression 
than other cognitive coping processes. They also found a negative significant 
relationship, between goal reengagement and depression.   
  Dickens et al. (2012) investigated perseverative negative cognitive 
process in patients with long-term conditions (LTCs), including CHD.  A 
relationship was found between RT and CHD and depression.  Depression was 
20% more likely with high worry, 10% more likely with thought suppression and 
22% more likely with thought avoidance.  Depression was strongly associated 
with thought suppression and thought avoidance. This provides evidence that 
perseverative negative cognition is associated with increased likelihood of 
depression in patients with LTCs, including CHD.   
Martens et al. (2006) compared post-MI patients to a clinically depressed 
psychiatric population. They found significantly higher rates of depressive 
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cognitions in the post-MI depressed group in comparison to the post-MI non-
depressed group, and higher rates again in the psychiatric population.  
Doyle et al. (2011a) measured the association of a range of 
psychological vulnerabilities (cognition distortions, Type-D personality, and 
interpersonal events) with depression in patients with an Acute Coronary 
Syndrome (ACS).  ACS is a specific heart condition which includes acute 
myocardial ischaemic states e.g. unstable angina (Grech & Ramsdale, 2003).  
They found the psychological vulnerabilities significantly predicted 22% of the 
variance for depression, with greater psychological vulnerability positively 
associated with increasing depression.  
There is limited cross-sectional research, thus, all authors recommended 
additional prospective and longitudinal research to better understand 
depression, RT and CHD relationship and to better infer causal directions 
(Dickens et al., 2012; Doyle et al., 2011b; Garnefski et al., 2009; Martens et al., 
2006).    
The cross-sectional studies all had adequate sample sizes with the 
smallest being 120 participants.  All the included studies failed to accurately 
measure cardiac symptoms or time since cardiac event.  This could be a key 
confounding factor for both rates of depression and RT.  Measurement of 
constructs varied greatly between the studies, thus conclusions should be 
drawn with caution.  Doyle et al. (2011b) measured cognitive distortions using 
the Belief in a Just World Scale (BJW-S, Furnham, 2003), which is arguably not 
a comprehensive measure of cognitive distortions (Doyle et al., 2011b) or RT.  
The study would have benefited from using more specific measures which 
would allow for specific cognitive processes to have been identified e.g. 
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rumination or worry.  Depression was measured on both the Hospital Anxiety 
and Depression Scale (HADS; Zigmond & Snaith, 1983) and Beck Depression 
Inventory- Fast Screen (BDI-FS: Beck, Steer, Ball, Ciervo, & Kabat, 1997); one 
item on the BDI-FS relating to suicide was omitted. The use of both measures 
was arguably unnecessary.  
There are additional reasons for why the results from these studies 
should be interpreted with caution. Firstly, Dickens et al.’s (2012) sample 
consisted of LTC of which only 31.6% were patients with CHD; the authors did 
not conduct disease specific analyses.  Furthermore, responses were only 
received from 66% of initially approached participants, which raises questions 
about the representativeness of those participants retained in the study and the 
generalisability of the findings.  Secondly, Doyle et al.’s (2011b) study does not 
clearly define their understanding of cognitive distortions, or provide separate 
analysis for them.  Cognitive distortions could include a range of constructs 
such as unhelpful thinking patterns, repetitive or ruminative thoughts or 
dysfunctional beliefs.  Lastly, Martens et al. (2006) study compared post-MI 
patients with clinically depressed psychiatric patients.  The study gives a limited 
inclusion and exclusion criteria, making it difficult to ascertain if all potential co-
morbidities were adequately screened for and are not skewing the results. For 
example, patients were excluded for a diagnosis of psychosis but there is no 
mention of other disorders such as PTSD, which could have a profound impact 
on depression (Campbell et al., 2007) and RT.  
Prospective Studies. The prospective studies expand the conclusions 
drawn from cross-sectional research.  They found that RT predicted depression 
in cardiac populations (Denton et al., 2012; Doyle et al., 2011a; Garnefski & 
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Kraaji, 2010). In particular, rumination was found to be a prospective predictor 
for levels of depressive symptoms (Denton et al., 2012; Garnefski & Kraaji, 
2010).   
Garnefski and Kraaji’s (2010) cross-sectional study in post-MI patients 
was continued prospectively for one-year to investigate changes from baseline 
measures. They found the specific cognitive processes of rumination, 
catastrophising, positive refocusing and goal adjustment predicted 39% of the 
variance in depression scores at a one-year follow-up.  Rumination and 
catastrophising had a significant positive association with depression.  Findings 
showed goal reengagement was associated with lower depressive symptoms at 
one year follow-up.  However, only 88 of the 139 participants were followed-up 
and it perhaps therefore not necessarily a true representative of a post-MI 
population.  
A three month prospective study found that rumination independently 
predicted depression severity in ACS (Denton et al., 2012) when controlling for 
baseline depression. This study included a large sample of 457 patients and 
retained 387 participants at three month follow-up, making the results reliable.  
Findings showed rumination independently predicted depression severity at 
three month follow-up.  The study measured a range of vulnerabilities that could 
then be controlled for including cognitive, behavioural, interpersonal and cardiac 
severity. 
Doyle et al.’s (2011a) cross-sectional study with ACS patients was 
continued prospectively for one-year. As would be expected they found baseline 
depression to be the largest predictor of depression at follow up.  They also 
found that cognitive distortions were significant independent predictors of 
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depression at one year follow-up.  Only 58% of participants were retained at 
one year follow-up, and the impact of this attrition is unknown; there is no 
evidence of a statistical analysis of respondents and non-respondents.  Given 
the large attrition rate, such analyses would have been beneficial to rule out any 
bias and better understand the population, for example it may have been the 
more severely depressed, those who were physically unwell, or those with more 
cognitive distortions that dropped out. 
In all of the prospective studies, patients were identified following a 
cardiac event, which meant that there was a lack of knowledge about pre-
cardiac event rumination.  Assessment of pre-cardiac event RT rumination 
would have determined if increased RT preceded the cardiac event or whether 
it was a consequence of the cardiac event and associated losses and 
unresolved goals (Martin & Tesser, 1996; Nolen-Hoeksema, 1991). 
The prospective studies also attempted to measure cardiac symptoms. 
Denton et al. (2012) used the Left Ventricular Ejection Fraction (LVEF), which 
categorised patients into four groups (mild to severe).  Garnefski and Kraaji’s 
(2010) study used the Physical Functioning Scale (Mchorney, Ware, Lu, & 
Sherbourne, 1994), which assesses QoL, as opposed to specific cardiac 
symptoms.  Although this is not a specific cardiac measure it allowed for 
physical health limitations to be controlled for.  Doyle et al. (2011a) did not 
include a specific measure of cardiac symptoms, but they did categorise 
participants by type of cardiac event or specific diagnosis, which allowed for 
differences between diagnoses to be investigated.   
Another methodological issue within the prospective research is a 
number of potential confounding factors were not measured and subsequently 
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controlled for.  For example, social support, personality (Garnefski & Kraaji, 
2010), QoL (Denton et al., 2012) and worry (Doyle et al., 2011a) were not 
assessed.   
  All of the prospective studies and cross-sectional studies, bar one 
(Martens et al., 2006), relied solely on self-report assessment measures.  
Potential disadvantages of self-report measures include response bias and 
incomplete measures. Potential advantages however are increased 
participation and less reliance on a research team to conduct assessments, 
making it more financially viable.  
Discussion 
Summary of Evidence 
 The studies outlined in this systematic review show that there is a cross-
sectional (Dickens et al., 2012; Garnefski et al., 2009) and prospective (Denton 
et al., 2012; Garnefski & Kraaji, 2010) relationship between RT and depression 
in cardiac populations.  This review highlights that there is very limited empirical 
research with a mere seven studies identified; therefore findings should be 
cautiously interpreted.  Several prospective studies have found RT to be a 
predictive factor for depression in CHD (Denton et al., 2012; Garnefski & Kraaji, 
2010); however, additional prospective longitudinal research is required to 
confirm these findings.  
This review has found insufficient evidence to support models (Brosschot 
et al., 2006; Larsen & Christenfeld, 2009) that propose RT causes continued 
and prolonged activation of the physiological systems worsening CHD and 
depression.  Further research is required to investigate the prolonged impact of 
RT on CHD and to expand on studies that have currently only used induced RT.  
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The research outlined in this review did not examine RT pre-cardiac event and 
this would be useful in understanding whether increased RT precedes a cardiac 
event or increases subsequent to a cardiac event (Denton et al., 2012). The 
current research does not enable inference of causal direction as prospective 
relationships could reflect a third factor predicting both depression and RT in 
CHD. Experimental manipulation of RT in CHD would provide more direct 
evidence of whether RT is a mechanism causing depression in CHD. 
Given the emerging evidence that RT is involved in the relationship 
between depression and CHD, research into potential effective psychological 
interventions for RT in CHD could be beneficial and help to understand the 
causal role of RT in depression in CHD populations.  Randomised controlled 
trials (RCTs) have shown enhanced depression care for CHD patients reduced 
depressive symptoms (Davidson et al., 2010) and psychological interventions 
improved depression outcomes (Whalley et al., 2011). Further RCTs are 
required to develop an evidence-based treatment for depression in cardiac 
populations (Davidson, Rieckmann, & Lesperance, 2004). 
There are a number of methodological issues with the studies included in 
this review, most importantly with initial recruitment (Dickens et al., 2012) and 
attrition for longitudinal research (Doyle et al., 2011a).  Going forward, research 
would benefit from improving recruitment rates (Dickens et al., 2012), and 
reducing attrition rates to gain a more representative CHD sample. In addition, 
findings may have greatly differed due to a variety of measurement tools being 
used; with almost all studies solely using self-report assessment. 
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Limitations 
The conclusions of this review are limited by a lack of experimental, 
retrospective, prospective research or clinical trials available.  This review has 
focused on RT; a wider review including other cognitive processes may add to 
the findings.   
Conclusions 
This systematic review of a small but emerging literature has confirmed a 
relationship between RT and depression in cardiac populations.  It was unable 
to establish the specific role of RT as a mechanism or risk factor.  Additional 
prospective longitudinal and experimental research is required to further support 
these conclusions.   
This review has highlighted a need for research focussing on the role of 
RT on the physiological system in order to test the hypothesis that RT prolongs 
activation and worsens CHD. Research that investigates pre-cardiac event 
depression and RT would be advantageous to understand the specific role that 
RT could play.  
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Abstract 
Objective: Theoretical and empirical evidence suggests a relationship between 
Repetitive Thought (RT, e.g. rumination), and depression in patients with 
Coronary Heart Disease (CHD).  To date, cross-sectional studies indicate that 
rumination is associated with depression in CHD, but additional prospective 
longitudinal research is required to determine if rumination predicts subsequent 
depression.  This research therefore aimed to test the hypothesis that RT, 
specifically rumination, is a vulnerability factor for depression over time in a 
CHD population.  It was predicted that RT at baseline would predict depression 
rates at three month follow-up after controlling for baseline depression and 
potential confounding factors. 
Methods: Inpatients and outpatients with a diagnosis of CHD completed self-
report questionnaires at baseline (N = 101) and at three month follow-up (N = 
85).  The data was analysed using a hierarchical multiple regression. 
Results: Baseline rumination significantly predicted depression at the three 
month follow-up after controlling for baseline depression and potential 
confounding factors.  Rumination accounted for 8.3% of the variance (p< .001). 
Subscales of brooding and reflection were also found to be individually 
predictive of follow-up depression explaining 4% of the variance (p< .005) and 
7% of the variance (p< .001) respectively.      
Conclusion: Findings are consistent with previous prospective and cross-
sectional research that indicates that rumination plays a unique role in the 
maintenance of depression in CHD patients and is an identifiable vulnerability 
factor. 
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Introduction  
Depression and Chronic Heart Disease (CHD)  
The ICD-10 defines depression to be when a patient suffers from at least 
one of three key symptoms (low mood, reduction in energy, activity, capacity for 
enjoyment or interest), which should be present on most days, most of the time 
and for at least two weeks (World Health Organisation, 2004). CHD includes 
angina, Acute Coronary Syndrome (ACS), and Myocardial Infarction (MI) or 
heart failure (NHS Choices, 2012).  CHD is also referred to as Coronary Artery 
Disease (CAD) and ischemic heart disease. 
Research has indicated elevated co-morbidity between CHD and 
depression (Goldston & Baillie, 2008).  A number of reviews have concluded 
that there is a causal bi-directional relationship between CHD and depression 
(Aromaa et al., 1994; Frasure-Smith & Lesperance, 2005, 2006; Goldston & 
Baillie, 2008; Kubzansky & Kawachi, 2000; Smith, 2001).  Depression has a 
prevalence rate of 20% or higher post-MI (Dickens et al., 2004; Lesperance & 
Frasure-Smith, 2000; Lett et al., 2004; Musselman, Evans, & Nemeroff, 1998). 
Carney and Freedland (2008) reported that approximately 20% of patients with 
CHD have severe depression and 20% have minor depression.  Depression 
has been found to be an independent (Ford, Mead, Chang, Cooper-Patrick, 
Wang, & Klag, 1998; Wulsin, 2004; Wulsin & Singal, 2003) and robust (Whooley 
& Wong, 2013) risk factor for worse cardiac outcomes in CHD.  Research 
indicates that depression is a risk factor for mortality and increased cardiac 
symptoms in patients with CHD (Appels, 1997, 2002; Barefoot, Brummett, 
Helms, Mark, Siegler, & Williams, 2000; Barth, Schumacher, & Herrmann-
Lingen, 2004; Dickens et al., 2008a; Frasure-Smith & Lesperance, 2003, 2005; 
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Goldston & Baillie, 2008; Kubzansky & Kawachi, 2000; Pogosova, 2012).  
Retrospective studies have demonstrated that depression precedes CHD 
(Dickens et al., 2005; Thiel, Parker, & Bruce, 1973), and it is proposed that 
depression increases the risk of CHD onset by 1.5-2 times (Lett et al., 2004).  
Recently research has proposed that Repetitive Thought (RT) could be a 
mechanism linking CHD and depression together (Denton, Rieckmann, 
Davidson, & Chaplin, 2012), building on work establishing RT as a risk factor for 
depression (Nolen-Hoeksema, Wisco, & Lyubomirsky, 2008). 
Depression and RT 
There are a number of potential relationships between CHD, depression 
and RT: e.g., (i) RT as common vulnerability factor for depression and CHD, (ii) 
RT as mediator of relationship between CHD and depression; (iii) RT as 
mediator of relationship between depression and CHD; (iv) RT as a moderator 
of relationship between depression and CHD, or (v) no causal relationships, but 
all factors associated with a common marker (e.g., neuroticism). To understand 
the CHD, depression and RT relationship it is important to consider relevant 
supported models which have been developed to understand the relationship 
between RT and depression.  
RT is defined as the “the process of thinking attentively, repetitively, or 
frequently about oneself and one’s world” (Segerstrom, Stanton, Alden, & 
Shortridge, 2003, p. 909).  An extensive review by Watkins (2008) outlined the 
constructs within  RT, including: worry, positive and negative rumination, post-
event rumination, perseverative cognition, emotional and cognitive processing, 
mental stimulation, planning, problem solving, rehearsal, reflection, 
counterfactual thinking, defensive pessimism and habitual negative self-thinking 
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(see appendix A for glossary of RT terms).  RT is positively correlated with 
anxiety and depression (De Jong-Meyer, Beck, & Riede, 2009; Hughes, Alloy, & 
Cogswell, 2008; Segerstrom, Tsao, Alden, & Craske, 2000).  Furthermore, 
rumination and worry have been found to be predictors of anxiety and 
depression (Muris, Roelofs, Meesters, & Boomsma, 2004). Several types of RT 
have been associated with depression including, worry (Harrington & 
Blankenship, 2002; Hoyer, Gloster, & Herzberg, 2009), mind-wandering 
(Smallwood, O'connor, Sudbery, & Obonsawin, 2007), counterfactual thinking 
(Quelhas, Power, Juhos, & Senos, 2008) and reflection (Takano & Tanno, 
2009).    
Depressive rumination is defined as “behaviors and thoughts that focus 
one's attention on one's depressive symptoms and on the implications of these 
symptoms” (Nolen-Hoeksema, 1991, p. 569).  Nolen-Hoeksema (1991) 
proposed the response style theory which argued that depressive rumination is 
a mode for responding to distressing symptoms and it involves repetitively 
focusing on symptoms of distress and the causes or consequences of the 
distress.  The continued ruminative response prolongs depression because 
individuals are focused on their negative emotional state and use negative 
biased thinking.  Experimental research has identified that rumination is 
positively associated with negative affect (Watkins, 2004).  Additionally, 
prospective research found rumination to be involved in the onset of depression 
(Nolen-Hoeksema, 2000). Rumination is an established factor that contributes 
to the onset, duration, severity and maintenance of depression (Nolen-
Hoeksema et al., 2008; Segerstrom et al., 2000; Watkins, 2008).  To date the 
effects of rumination on the development of depression have been studied in 
patients with depression or general community samples. However, it seems 
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likely that these consequences of RT would also extend to patients with CHD 
and potentially account for elevated depression.   
Moreover, RT can also be understood in terms of Control Theory, which 
proposed that goal discrepancies result in rumination (Martin & Tesser, 1996).  
If there are discrepancies between an individual’s perceived and desired rate of 
goal progress (Carver & Scheier, 1990) they will ruminate about it.  Unresolved 
goals will lead to rumination until the goal is resolved or abandoned. Rumination 
about goal attainment continues despite the likelihood of it being achievable and 
can be in order to make sense of an event (Martin & Tesser, 1996). Recent 
research supported this theory, finding that thinking about unresolved goals 
increased ruminative thoughts (Roberts, Watkins, & Wills, 2013).  
Is RT a linking mechanism between CHD and depression? 
RT is associated with depression in CHD populations (Denton et al., 
2012; Garnefski & Kraaji, 2010).  Because RT contributes to the onset and 
maintenance of depression, it is likely that this process occurs in CHD patients, 
consistent with the response styles theory.  Moreover, for CHD patients 
following a life-changing event such at an MI or diagnosis of CHD, they are 
likely to be focusing on negative symptoms of distress and the causes or 
consequences of the distress (Nolen-Hoeksema, 1991).  Therefore, CHD 
patients are likely to be ruminating about what they could have done differently, 
what will happen now and losses they have experienced e.g. in their ongoing 
health, life ambitions and mortality.  It is then not surprising that emerging 
evidence has shown a link between RT and depression within a CHD 
population (Denton et al., 2012) and that rumination could be an important 
coping strategy (Garnefski & Kraaji, 2010).  If additional prospective research of 
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CHD patients found rumination predicted change in depression levels over time 
it would support and extend the response styles theory to a CHD population, 
this will be tested in the current research.  Additionally, when considering 
Control Theory (Carver & Scheier, 1990), there is a potential that the impact of 
a severe cardiac event could significantly alter goal attainment and leave 
unresolved goals, resulting in increased ruminative thoughts (Roberts et al., 
2013).   
Several theoretical models propose that RT could be involved in the 
onset and maintenance of CHD.  Larsen and Christenfeld (2009) hypothesise 
that co-morbidity between CHD and depression could be a result of a state of 
cognitive and autonomic inflexibility.  They note that rumination has been shown 
to impact physiological recovery and consequently cardiac health.  Therefore, 
increased rumination, worry and obsessions, could increase sympathetic 
arousal leading to lower heart rate variability and reduced vagal tone.  They 
hypothesise that rumination mediates physiological and psychological 
symptoms and outcomes by extending sympathetic arousal, and that this could 
become a perpetuating cycle.   Thus, rumination could both cause and extend 
physiological arousal affecting both cardiac and depression outcomes.  This 
theory suggests that rumination is a shared vulnerability factor for both 
depression and CHD.  To test Larsen and Christenfeld’s theory patients would 
ideally need to be recruited pre-cardiac event and have a medical measure of 
cardiac symptoms; therefore this cannot be tested in the current study. 
Larsen and Christenfeld’s (2009) hypothesis extended an earlier model 
by Brosschot, Gerin, and Thayer (2006); this model did not include the potential 
influence of depression but supports the hypothesis that RT plays an important 
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role in CHD.  Brosschot et al. (2006) propose that perseverative cognition, 
defined as “the repeated or chronic activation of the cognitive representation of 
one or more psychological stressors” (p. 2) and manifested as worry or 
rumination, mediates health consequences by creating continued activation of 
physiological systems.  Their model has been supported by experimental 
research, which found that perseverative cognition delayed cardiac recovery 
(Verkuil, Brosschot, De Beurs, & Thayer, 2009) and elevated blood pressure 
(Gerin, Davidson, Christenfeld, Goyal, & Schwartz, 2006; Glynn, 2002).   
Research has linked RT and depression with CHD.  Rumination and 
catastrophising are associated with higher depressive symptoms post-MI and at 
one year follow-up (Garnefski & Kraaji, 2010; Garnefski et al., 2009).  Dickens 
et al. (2012) found a link between RT and CHD and depression.  Depression 
was 20% more likely with high levels of worry, 10% more likely with thought 
suppression and 22% more likely with thought avoidance.  Cognitive distortions 
have been found to be predictors of depression in CHD (Doyle, Mcgee, 
Delaney, Motterlini, & Conroy, 2011a; Doyle, Mcgee, Conroy, & Delaney, 
2011b; Stafford, Jackson, & Berk, 2009), indicating that cognitive process play a 
role in depression and CHD.  The research outlined indicates a relationship 
between RT, CHD and depression, but the specific mechanism that RT may 
play and extent of the mechanism has not clearly been established. 
To our knowledge, only one prospective longitudinal study has 
specifically examined  RT as a mechanism or vulnerability factor for depression 
in CHD (Denton et al., 2012).  After controlling for baseline depression and 
cardiac disease severity, cognitive, behavioural, interpersonal vulnerabilities 
including rumination were longitudinally associated with depression severity 
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following an Acute Coronary Syndrome (ACS). ACS refers to a range of acute 
myocardial ischaemic states, which can include unstable angina, non-ST 
segment elevation myocardial infarction, and ST segment elevation infarction 
(Grech & Ramsdale, 2003), ACS is a specific diagnosis that would come under 
a broader heading of CHD.  This study was conducted in the USA, it included 
both men and women admitted with ACS and patients were assessed within 7 
days of admission.  They had an overall longitudinal retention rate of 85%, 
which equated to 387 participants.  The study categorised patients as 
depressed or non-depressed, excluding patients with a Beck Depression 
Inventory (BDI; Beck, Steer & Carbin, 1988) score of 5-9. This could have 
impacted on overall representation of the ACS population.  The study found 
depression severity at three month follow-up was independently predicted by 
rumination (specifically brooding).  This research indicates that rumination may 
play a role in worsening depression in non-depressed and previously depressed 
patients following ACS.  Given the emerging nature of the research, further 
prospective longitudinal research is needed to investigate if rumination is a 
predictive factor for depression in cardiac populations.   
CHD, depression and Quality of Life (QoL) 
QoL is significantly associated with depressive symptoms in cardiac 
patients (Ruo, Rumsfeld, Hlatky, Liu, Browner, & Whooley, 2003).   Pragodpol 
and Ryan’s (2013) review of Health Related Quality of Life (HRQoL) in a CHD 
population, found HRQoL was predicted by socio-demographic, clinical and 
psychosocial factors, and concluded that depression was a negative predictor of 
HRQoL.  Foxwell, Morley, and Frizelle (2013) found illness perceptions 
predicted QoL and mood across CHD.  Dickens, Cherrington, and Mcgowan 
(2011) found that depression was associated with HRQoL in patients with CHD; 
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it was mediated by negative illness perceptions, cardiac anxiety, and awareness 
of somatic symptoms.  The more patients with CHD thought about their illness 
and their symptoms the worst their HRQoL.  Additionally, cardiac patient’s 
illness perception schemata was closely associated with depressive symptoms 
and QoL, irrelevant of socio-demographic background and diagnostic category 
(Le Grande et al., 2012).  Cardiac patients’ recovery from surgery has also been 
found to be influenced by their pre-surgery illness beliefs (Juergens, Seekatz, 
Moosdorf, Petrie, & Rief, 2010).  There are no known studies that have 
specifically investigated the role of RT on QoL or HRQoL in patients with CHD.  
Further research investigating this would need to control for depression given 
the association that has been identified. 
To date, the direction of causality between rumination and depression in 
CHD has not been definitively established (Glassman, 2008).  Further research 
is needed to specifically understand the mechanisms linking CHD and 
depression (Poole, Dickens, & Steptoe, 2011) and whether any specific risk 
factors or mechanisms such as rumination can be identified as increasing 
depression rates in CHD patients.  Hence, this study will test the hypothesis that 
rumination is a mechanism that contributes to increased depression in CHD, by 
examining whether RT at baseline predicts increases in depression symptoms 
over time.  This study aims to replicate the recent research by Denton et al. 
(2012) to see if the role of rumination in depression and in CHD can be more 
definitively established.  It will extend Denton et al.’s (2012) study in the 
following ways: 1) by conducting it in the UK, 2) with a broader cardiac 
population which will include CHD, ACS and post-MI patients, 3) by including all 
patients irrelevant of their baseline depression score to reflect a more 
representative CHD population, and 4) to include both inpatients and 
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outpatients at a range of treatment stages.  The study will aim to gather 
evidence for relevant models and theories (Brosschot et al., 2006; Carver & 
Scheier, 1990; Larsen & Christenfeld, 2009; Nolen-Hoeksema, 1991). Based on 
this hypothesis, we predicted that RT (rumination) at baseline will predict higher 
rates of depression at three month follow-up when controlling for depression 
and cardiac QoL at baseline.   
In addition two secondary hypotheses were also investigated. A strong 
association between CHD, depression and QoL has been established (Ruo et 
al., 2003).  Furthermore reviews have found illness perceptions predicted QoL 
and depression across CHD (Foxwell, Morley,& Frizelle, 2013), which suggests  
there are cognitive processes involved in the relationship between CHD, QoL, 
and depression.  One hypothesis is that continued rumination about patients’ 
illness perceptions maintains or worsens depression and impacts on their 
perceived QoL.  Previous research has found that RT, specifically 
counterfactual thinking, worsened QoL in health domains in women having 
breast implants (Parker, Middleton & Kulik, 2002) and negative thoughts have 
be found to moderate and partially mediate the influence of pain intensity on 
mental QoL in patients with haemophilia (Elander, Robinson, Mitchell & Morris, 
2009). There is thus evidence that RT is potentially associated with QoL 
outcomes in health conditions.  There are no known studies that have 
investigated whether over time rumination maintains or worsens QoL in patients 
with CHD. It would also be important to control for the effects of depression.  
Therefore, the second hypothesis of this study will test if rumination is a 
mechanism that contributes to worsened cardiac QoL in CHD. We predicted 
that RT (rumination) at baseline will predict higher rates of cardiac QoL at three 
month follow-up when controlling for depression and cardiac QoL at baseline. 
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In addition to measuring general QoL, it is also important to see if there is a 
prospective relationship between cardiac specific QoL and rumination over time.  
Although cardiac QoL may overlap with general QoL, it may also tap into more 
specific issues within this population.  Additionally, cardiac QoL measures such 
as the Seattle Angina Questionnaire (SAQ) have been argued to be valid 
measures of cardiac symptoms (Spertus et al., 1995).  Measurement of cardiac 
symptoms therefore tests whether rumination at baseline worsens both cardiac 
and depression outcomes over time, consistent with the predictions of theories 
which propose that RT causes and maintains both depression and cardiac 
symptoms in a CHD population (Brosschot et al, 2006; Larsen & Christenfeld, 
2009).  Therefore the final hypothesis will test if rumination is a mechanism that 
contributes to worsened QoL in CHD. We predicted that RT (rumination) at 
baseline will predict worse QoL at three month follow-up when controlling for 
depression, QoL, and cardiac QoL at baseline. 
Method 
Design 
This was a prospective longitudinal study with a three month follow-up. 
This questionnaire based study aimed to examine the relationship between 
variables including: depression, RT, cardiac QoL and QoL measured by self-
report questionnaires in a CHD population.   
Participants and recruitment procedure 
A total of 101 participants (77 men and 24 women) were recruited from 
Royal Devon and Exeter Hospital (RD&E), Cardiology Unit through cardiac 
admissions and the cardiac rehabilitation group.  Inclusion criteria at recruitment 
was that participants were (i) aged between 18-85 years of age, modal age was 
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66-75 years old, (ii) patients with CHD (including post-MI or with a diagnosis of 
CHD or angina), with a diagnosis confirmed by a Consultant Cardiologist and 
Specialist Cardiac Nurse who signposted suitable patients, (iii) inpatients or 
outpatients at RD&E hospital presenting for cardiac care, (iv) were English 
native speakers, to maintain the validity of the questionnaires, and (v) had given 
informed consent to participate.  Exclusion criteria included (i) neurological 
illness or head injuries, (ii) current psychosis or schizophrenia, or (iii) a learning 
difficulty.  The exclusion criteria were assessed by the researcher during the 
initial contact and using information provided by the medical staff.  
Potential participants were initially approached by cardiac staff whilst 
they were inpatients or at follow-up cardiac rehabilitation group.  If they were 
willing to discuss potential participation they were signposted to the researcher. 
The researcher spent time with the participants to talk through the information 
sheet, consent forms, provide an opportunity to ask any questions and assess 
their suitability using the inclusion and exclusion criteria.  Participants were 
offered twenty-four hours to consider their consent.  If participants met the 
criteria and wanted to participate they were allocated a participant pack (see 
appendix B), consisting of the consent form, consent to contact sheet and study 
questionnaire in their preferred format (an emailed on-line link or paper copy 
with stamped addressed envelope).  101 participants completed the initial 
questionnaire (82 on paper; 19 via online survey using LimeSurvey, 2012).   
Three months later participants completed an identical set of 
questionnaires to those that were completed at baseline, sent by their preferred 
method (email, post).  If participants had not returned the questionnaire within 
two weeks they were contacted by the researcher and prompted to return it.  
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Eighty-five of the participants completed the three month follow-up 
questionnaire. Of the 16 non-responders, three had died during the three month 
follow up. The overall retention rate was 82.83%.  Where items were omitted on 
the questionnaires, the researcher followed up to confirm and complete the 
forms, as appropriate.  
Ethical approval and considerations 
The study was approved by the National Health Service (NHS) Research 
Ethics Committee in Exeter (ref: 13/SW/0062), the Department of Psychology at 
the University of Exeter (ref: 2012/846) and the RD&E research and 
development department (ref: 1401879).  See appendix C for further details. 
All participants were provided with details of support organisations and 
contacts.  Participants were also informed that if they were identified as having 
above moderate depression that their general practitioner (GP) would be 
informed.  Where consent was obtained, letters outlining the study were sent to 
participants GPs.   
Measures 
All measures were consolidated into one questionnaire pack to improve 
usability. A demographic questionnaire asked about age range, gender, 
ethnicity, marital status, employment status, smoking status (former, current, 
never), alcohol consumption (units in past week), perceived social support, 
hours exercised, diet, BMI and health conditions.  It also captured information 
pertaining to the CHD such as the duration of diagnosis, number of acute 
events, and the date of last acute event. 
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The Patient Health Questionnaire-(PHQ-9).  The PHQ-9 (Kroenke, 
Spitzer, & Williams, 2001), is a widely used brief self-report nine item 
questionnaire, which measures severity of depression.  Symptoms of 
depression are rated from “not at all” to “nearly every day”.  Higher scores 
indicate more severe depression (range 0-27) with scores interpreted with 
respect to severity of depression: minimal (0-4), mild (5-9), moderate (10-14), 
moderately severe (15-19) or severe (20-27).  It can be used as a diagnostic 
tool (Martin, Rief, Klaiberg, & Braehler, 2006; Spitzer, Kroenke, Williams, & The 
Patient Health Questionnaire Primary Care Study, 1999) or screening tool.  The 
PHQ-9 is a valid and reliable brief measure of the severity for depression, with 
Cronbach’s alpha of 0.89  (Kroenke et al., 2001).  In this study Cronbach’s 
alpha had a high reliability of 0.92. It has been found to be a superior measure 
to the Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) 
for detecting severe depression (Lowe, 2004). It is widely used in medical 
settings (Gilbody, Richards, Brealey, & Hewitt, 2007) and for screening 
depression in CHD patients (Lichtman et al., 2008) where it has also been 
found to be diagnostically superior (Haddad et al., 2013) to the HADS.    
Rumination Response Scale of the Response Styles Questionnaire 
(RRS). The RRS (Treynor, Gonzalez, & Nolen-Hoeksema, 2003), is a twenty-
two item measure which assesses depressive rumination.  Participants rate the 
frequency that they use ruminative strategies from “almost never” to “almost 
always”, higher scores indicate higher levels of rumination (range 22-88).  It 
contains two sub scales that specifically assess reflection and brooding. The 
RRS has been found to have good reliability with a Cronbach’s alpha of 0.89 
(Nolen-Hoeksema & Morrow, 1991).  In this study Cronbach’s alpha had a high 
reliability of 0.97.  Good reliability has been replicated by later studies (Roelofs, 
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Muris, Huibers, Peeters, & Arntz, 2006).  It has been used in previous cardiac 
research (Denton et al., 2012). 
Seattle Angina Questionnaire (SAQ).  The SAQ (Spertus et al., 1995), 
is a 19 item self-administered questionnaire. The SAQ measures health related 
quality of life and is specific to cardiac symptoms.  Questions are grouped into 
five sub-categories which include physical limitation, anginal stability, anginal 
frequency, treatment satisfaction and disease perception and are scored by 
percentage (range 0-500).  The SAQ has been found to be a valid measure of 
cardiac symptoms (Spertus et al., 1995).  It has acceptable re-test reliability with 
Cronbach’s alpha ranging from 0.65 to 0.96 (Dougherty, Dewhurst, Nichol, & 
Spertus, 1998), in this study there was a Cronbach’s alpha of 0.66.  The SAQ is 
specifically aimed at patients with angina; it was therefore explained to 
participants that if they do not have chest pains then they should relate the 
questions to their specific CHD symptoms. 
Health Related Quality of Life- Short Form-12 (SF12).  The SF-12 
(Ware, Kosinski, & Keller, 1996) is a twelve item self-report health related 
quality of life measure. It measures eight concepts of health status: physical 
functioning, role limitations due to physical health problems, bodily pain, general 
health, vitality (energy/fatigue), social functioning, role limitations due to 
emotional problems, and mental health.  The measure was scored using 
scoring software (Quality Metrics, V.4.5).  The SF-12 has been found to be a 
valid and reliable measure (Globe, Levin, Chang, Mackenzie, & Azen, 2002).  It 
has a Cronbach’s alpha ranging from 0.68 to 0.94 (Gandek et al., 1998), in this 
study a high Cronbach’s alpha of 0.88 was found.   It is also a robust measure 
for use with CHD patients (Melville, Lari, Brown, Young, & Gray, 2003). 
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New York Heart Association classification (NYHA). The NYHA is 
used to classify heart failure in order to inform diagnosis and treatment 
(Swedberg et al., 2005).  The NYHA is widely used and has been found to be a 
valid and reliable measure both clinically and for the purposes of research 
(Bennett, Riegel, Bittner, & Nichols, 2002).  The NYHA has a Cronbach’s alpha 
of 0.94 (Moser & Riegel, 2000). The NYHA has four criterion: class I: no 
symptoms and limitation in ordinary activities; class II: mild symptoms and slight 
limitation in ordinary activities; class III: marked limitation in activities; class IV: 
severe limitations.  This classification measure was the most widely used at the 
recruitment site and therefore the most available and reliable measure of 
cardiac severity for this sample. 
Results 
Preliminary Analysis  
Descriptive Statistics.  A summary of the sample demographic 
statistics are shown in Table 1.  As is typical with a CHD population, there are 
more men than women and there are higher rates of participants with a BMI 
outside the healthy range (64-71%) in comparison to the general population 
(61.3%; Department of Health, 2010).  There is also a diabetes prevalence rate 
of 19.9%, which is above the national average of 4.6% (Diabetes UK, 2013). 
Half of participants also stated that they had an additional health condition other 
than CHD.  The modal age range was 66-75, with 51.5% of participants retired.  
Reflecting the demographics of the recruitment area (Exeter), 98% of 
participants identified themselves as White British.   
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Table 1.  
Sample demographic characteristics 
Characteristic Full sample recruited (N=101) 
Age in years (range) 
 
10 (36-45)      34 (66-75) 
27 (56-65)      18 (76-85) 
Gender (n) 77 (Male) 24 (Female) 
Employment n (%) 
Employed full time/part-time 
Retired 
Full-time homemaker or carer 
 
33 (32.7)/ 7 (6.9) 
52 (51.5) 
3 (3.0) 
Marital status n (%) 
Married 
Single 
Co-habiting/Civil union 
Widowed 
Divorced 
 
73 (72.3) 
3 (3.0) 
6 (5.9)/ 1 (1.0) 
8 (7.9) 
10 (9.9) 
Ethnicity n (%) 
White British 
Other 
Not stated 
 
99 (98.0) 
1 (1.0) 
1 (1.0) 
Smoking status n (%) 
Never smoked 
Former smoker 
Current smoker 
 
31 (30.1) 
62 (61.4) 
8 (7.9) 
Alcohol consumed n (%) 
No/Yes 
 
33 (32.7)/67 (66.3) 
Exercise n (%) 
No/Yes 
 
18 (17.8)/82 (81.2) 
Diabetes n (%) 
No 
Type 1 
Type 2 
Missing data 
 
80 (79.2) 
5 (5.0) 
15 (14.9) 
1 (1.0) 
Other health conditions n (%) 
No  
Yes 
Missing data 
 
48 (47.5) 
48 (47.5) 
4 (4.0) 
Body Mass Index (BMI) n (%) 
Healthy weight 
Overweight 
Obese 
Severely obese/Morbidly obese 
Missing data 
 
29 (29.0) 
32 (32.1) 
26 (26.0) 
3 (3.0)/4 (4.0) 
7 (6.9) 
Number of acute cardiac events n (%) 
0 
1 
2 
≥3 
 
11 (10.9) 
48 (47.5) 
15 (14.9) 
16 (15.9) 
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Mean, standard deviations (SD) and ranges for the key variables (PHQ, 
RRS, SAQ and SF12) at baseline and follow-up were reported (Table 2).  
Examining the scores, there is a reduction in rumination (RRS), depression 
(PHQ), and QoL (SAQ) scores from baseline to follow-up and an increase in 
cardiac QoL (SF-12).  The largest portion (60%) of participants had minimal 
depression. However, 21% of participants received depression scores within the 
moderate to severe range, consistent with previous research which 
demonstrated post-MI 21% suffered with depression (Dickens et al., 2004). 
Table 2. 
Summary of key variables ranges, means, and SD’s. 
 
Measure N Range Minimum Maximum Mean SD 
T1 T2 T1 T2 T1 T2 T1 T2 T1 T2 T1 T2 
PHQ 101 84 27 26 0 0 27 26 5.77 4.15 6.70 5.11 
RRS 101 84 62 56 22 22 84 78 35.91 33.38 13.67 12.91 
SAQ 100 79 408 377 87 123 495 500 335 367 88.51 73.46 
SF12 97 81 675 663 25 37.5 700 700 400 445 168.02 167.68 
Note. T1 (Baseline), T2 (Follow-up), Depression (PHQ), full rumination measure 
(RRS), Cardiac QoL (SAQ), QoL (SF-12). 
Tests of normality and outliers.  Boxplots were used to identify and 
explore outliers. Histograms were created for the continuous key variables and 
visually examined for skewness and kurtosis and converted to z-scores 
(standard residuals) as recommended by Field (2013). Some participants were 
significantly different from the normal distribution on measures of depression 
and rumination at baseline and follow-up (Appendix D1).  Due to the nature of 
the hypotheses, it was important that the depression and rumination scores 
were truly representative of the sample. Therefore the data was left in its 
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original state and was not subject to any transformation. Additionally, the 
analyses of correlation and multiple regression are robust to deviations from 
normality so the data met this assumption adequately.  Parametric assumptions 
of the regression were checked prior to the evaluation of the model as 
recommended by Field (2013).   
Preliminary analysis.  Pearson correlations between all variables were 
investigated in order to examine relationships and identify any confounding 
variables.  Key variables measuring depression (PHQ), rumination (RRS), 
cardiac QoL (SAQ), QoL (SF12) baseline score were correlated with their 
corresponding follow-up score.  All key variables were also correlated with each 
other at p< .001 level, see Table 3.  
Previous research into depression and CHD has identified that age, 
gender, and social support can be confounding variables (Brosschot et al., 
2006).  Correlation matrix (Table 3 below) shows age was found to be 
significantly correlated with rumination (RRS), r(99)= -.232, p< .05 and time 
since diagnosis r(99)= .227, p< .05.  Social support was significantly correlated 
with rumination (RRS), r(96)= -.354, p<.001.  BMI was significantly correlated 
with age r(93)= -.255, p< .05, and depression (PHQ) r(93) = .295, p< .005.  A 
one-way ANOVA was conducted to test the association of gender on 
rumination.  There was a statistically significant difference, F (1,99)= 5.158, p< 
.05, finding that women (Mean 41.33, SD 16.42) had higher rumination scores 
than men (Mean 34.22, SD 12.34), consistent with the wider literature (Nolen-
Hoeksema & Jackson, 2001).  Age, gender, social support, and BMI are 
potential confounding variables and were therefore controlled for in the later 
regression analyses.   
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Table 3.  
Correlation matrix of variables 
 
Age 
Gen-
der BMI TSD SS 
PHQ 
T1 
PHQ 
T2 
RRS 
T1  
RRS 
T2 
SF12 
T1 
SF12 
T2 
SAQ 
T1  
SAQ 
T2 
Age 1             
Gender .136 1            
BMI -.255* .184 1           
Time since 
diagnosis 
.227* .079 .033 1          
Social 
support 
-.083 -.199 .049 -.057 1         
PHQ 
score T1 
-.144 .089 .295** .059 -.098 1        
PHQ 
score T2 
-.201 .006 .434** .047 -.210 .727** 1       
RRS T1 -.232* .223* .180 .050 -.354** .687** .729** 1      
RRS T2 -.248* .075 .292** -.008 -.316** .698** .821** .865** 1     
SF12 T1 -.056 -.139 -.185 -.128 .135 -.597** -.469** -.510** -.432** 1    
SF12 T2 -.111 -.019 -.283* -.229* .084 -.583** -.674** -.476** -.536** .756** 1   
SAQ T1 -.003 -.022 -.093 -.020 .100 -.487** -.341** -.362** -.297** .673** .552** 1  
SAQ T2 -.201 -.036 -.164 -.203 .091 -.367** -.323** -.295** -.316** .551** .679** .496*
*
 
1 
Note. Coding of items, age (0= 18-25, 1= 26-35, 2= 36-45, 3= 46-55, 4= 56-65, 5= 66-
75, 6= 76-85, 7= 85 and over), gender (0= male, 1= female), time since diagnosis 
(number of days since diagnosis), social support (0= none of the time, 1= a little of the 
time, 2= some of the time, 3= most of the time, 4= all of the time).  
*. Correlation is significant at the 0.05 level (2-tailed), **. Correlation is significant at 
the 0.01 level (2-tailed), T1 (baseline, T2 (follow-up).  
 
The follow-up questionnaire was completed by eighty-five participants. In 
the sixteen participants that did not complete the follow-up, three are known to 
have died and one participant’s health meant that they were too poor to 
complete the questionnaire.  Further analyses (t-test, chi-square) tested if there 
were any differences at baseline between those participants who completed the 
follow-up versus those who did not.  No significant differences were found 
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between participants that completed follow-up and those that did not                 
X2 (4) = 6.59, p > .05, t(99) = 3.14, p > .05.   
The data collected for the NYHA only allow patients to be categorised 
into four categories; within the current dataset all participants ended up in one 
of two categories, which meant this data was not appropriate to use in the 
analysis.  The SAQ will be used as it has been argued to be a valid measure of 
cardiac symptoms (Spertus et al., 1995) and it provides more information than 
the few discrete categories that the NYHA provides.  Therefore the SAQ is more 
likely to show if there is any variation in cardiac symptoms over time for this 
sample. 
Main analyses 
Principal hypothesis: RT (rumination) at baseline will predict higher rates of 
depression at three month follow-up when controlling for depression and 
cardiac QoL at baseline. 
To test the principal hypothesis, a hierarchical multiple regression was 
conducted with depression (PHQ) at follow-up as the dependent variable.  
Baseline depression (PHQ) was entered at the first step in the regression 
equation; cardiac QoL and potential confounding variables of age, BMI, gender, 
and social support were added at step two, and then the independent variable 
of RT (RRS) was added at step three. The model met parametric assumptions 
as recommended by Field (2013).  
The overall model was significant, F(7, 78) = 29.456, p<.001. As 
expected, baseline depression significantly predicted depression three months 
later, accounting for 61% of the variance.  Consistent with the hypothesis, 
rumination at baseline was a significant additional predictor of depression at 
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follow-up after controlling for baseline depression, age, gender, BMI, social 
support and cardiac QoL, accounting for an additional 8.3% of the variance,      
F(1, 71) = 22.135, p<.001, with a positive directional effect.  Table 4 shows the 
individual predictors that contributed significantly to explain depression scores 
at three month follow-up.   
 
 
Table 4. 
Results of hierarchical multiple regression for the principal hypothesis  
 
 Model Β SE (B) Beta t 
1. Constant 
Total PHQ (T1) 
.693 
.671 
.479 
.061 
 
.783*** 
1.446 
11.031 
2. Constant 
Total PHQ score 
Total SAQ  
Age 
Gender 
BMI 
Support available 
-4.002 
.599 
.001 
.048 
-.248 
.234 
-.598 
3.634 
0.72 
.005 
.327 
.899 
.084 
.339 
 
.699*** 
.013 
.011 
-.022 
.213** 
-.122 
-1.101 
8.261 
.169 
.146 
-.316 
2.799 
-1.766 
3. Constant 
Total PHQ score 
Total SAQ  
Age 
Gender 
BMI 
Support available  
Total RRS (T1) 
-10.896 
.304 
-.001 
.215 
-.942 
.241 
-.228 
.202 
3.515 
.089 
.004 
.290 
.803 
.073 
.308 
.043 
 
.355*** 
-.011 
.048 
-.073 
.219** 
-.047 
.460*** 
-3.100 
3.404 
-.158 
.742 
-1.173 
3.277 
-.740 
4.705 
Note. Depression (PHQ), Cardiac QoL (SAQ), rumination measure (RRS) and 
body mass index (BMI). Adjusted R2  = .607 for step 1, R2  = .636 for step 2, ∆ 
R2 = .083 for step 3 (p < .001). * p < .05, ** p < .01, *** p < .001. 
     
The relationship between depression over time and rumination was 
examined in Figure 1.  The scatterplot shows that as baseline rumination 
increases, there is a greater depression at follow-up, after controlling for 
baseline depression. 
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Figure 1. Change in depression from baseline to follow-up (standardised 
residual) as a function of baseline rumination. 
 
Previous research (Denton et al., 2012) had found that the subscales 
brooding and rumination of the RRS explained different variance in depression 
at three month follow-up.  These subscales were also tested using separate 
hierarchical multiple regressions identical to above but entering the reflection or 
brooding subscales instead of the full RRS score.   
For reflection, the overall model was significant, F(7, 78) = 27.745, 
p<.001. Depression at baseline significantly predicted depression three months 
later, accounting for 61% of the variance.  Reflection at baseline was a 
significant additional predictor of depression at follow-up after controlling for 
baseline depression, age, gender, BMI, social support and cardiac QoL, 
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accounting for an additional 7.0% of the variance, F(1, 71)= 18.110, p<.001, 
with positive directional effect.  Table 5 shows the individual predictors that 
contributed significantly to explain depression scores at three month follow-up.   
 
Table 5. 
Results of hierarchical multiple regression for the principal hypothesis for 
reflection 
 
 Model Β SE (B) Beta t 
1. Constant 
Total PHQ (T1) 
693 
.671 
.479 
.061 
 
.783*** 
1.446 
11.031 
2. Constant 
Total PHQ score 
Total SAQ  
Age 
Gender 
BMI 
Support available 
-4.002 
.599 
.001 
.048 
-.248 
.234 
-.598 
3.634 
0.72 
.005 
.327 
.899 
.084 
.339 
 
.699*** 
.013 
.011 
-.022 
.213** 
-.122 
-1.101 
8.261 
.169 
.146 
-.316 
2.799 
-1.766 
3. Constant 
Total PHQ score 
Total SAQ  
Age 
Gender 
BMI 
Support available  
RRS-Reflection 
-8.808 
.404 
.000 
.308 
-1.430 
.218 
-.418 
.743 
3.457 
.080 
.004 
.301 
.852 
.075 
.307 
.175 
 
.472*** 
-.003 
.069 
-.111 
.199** 
-.086 
.375*** 
-2.548 
5.083 
-.046 
1.024 
-1.679 
2.900 
-1.359 
4.256 
Note. Depression (PHQ), cardiac QoL (SAQ), rumination reflection subscale 
(RRS-reflection) and body mass index (BMI). Adjusted R2  = .607 for step 1, R2  
= .636 for step 2, ∆ R2 = .070 for step 3 (p < .001). * p < .05, ** p < .01, *** p < 
.001  
For the subscale of brooding the overall model was significant, F(4, 78) = 
24.298, p<.001. Depression at baseline significantly predicted depression three 
months later, accounting for 61% of the variance.  Brooding at baseline was a 
significant additional predictor of depression at follow-up after controlling for 
baseline depression, age, gender, BMI, social support and cardiac QoL, 
accounting for an additional 4.0% of the variance, F(1, 71) = 10.004, p<.005, 
with a positive directional effect.  Table 6 shows the individual predictors that 
contributed significantly to explain depression scores at three month follow-up.   
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Table 6. 
Hierarchical multiple regression for the principal hypothesis for brooding 
 
Model β SE (B) Beta t 
1. Constant 
Total PHQ (T1) 
.693 
.671 
.479 
.061 
 
.783*** 
1.446 
11.031 
2. Constant 
Total PHQ score 
Total SAQ  
Age 
Gender 
BMI 
Social support 
-4.002 
.599 
.001 
.048 
-.248 
.234 
-.598 
3.634 
0.72 
.005 
.327 
.899 
.084 
.339 
 
.699*** 
.013 
.011 
-.022 
.213** 
-.122 
-1.101 
8.261 
.169 
.146 
-.316 
2.799 
-1.766 
3. Constant 
Total PHQ score 
Total SAQ  
Age 
Gender 
BMI 
Social support  
RRS-Brooding 
-8.147 
.441 
-001 
.142 
-.602 
.245 
-.295 
.501 
3.669 
.085 
.005 
.310 
.853 
.079 
.333 
.158 
 
.515*** 
-.018 
.032 
-.047 
.223** 
-.060 
.281** 
-2.221 
5.218 
-.248 
.458 
-.705 
3.103 
-.885 
3.163 
Note. Depression (PHQ), cardiac QoL (SAQ), rumination brooding subscale 
(RRS-Brooding) and body mass index (BMI). Adjusted R2  = .607 for step 1, R2  
= .636 for step 2, ∆ R2 = .04 for step 3 (p < .005). * p < .05, ** p < .01, *** p < 
.001  
Hypothesis 2: RT (rumination) at baseline will predict higher rates of cardiac 
QoL three month follow-up when controlling for depression and cardiac QoL 
symptoms at baseline. 
Hypothesis 2 was tested using a hierarchical multiple regression, with 
cardiac QoL (SAQ) at follow-up, the dependent factor in this model.  Baseline 
cardiac QoL was entered in the first step of the regression equation, baseline 
depression (PHQ), and potential confounding variables of age, gender, BMI, 
and social support were added at step two, lastly, RT (RRS) was added at step 
three.   
The overall model was significant, F(7,73) = 6.619, p<.001. As expected, 
baseline cardiac QoL significantly predicted cardiac QoL three months later, 
accounting for 28% of the variance.  Contrary to the hypothesis, rumination at 
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baseline did not significantly predict any additional variance after controlling for 
baseline depression, age, gender, BMI and social support, F(1, 66) = 1.485, p 
>.05.  Summary of the model can be seen in Table 7.  
Table 7. 
Results of hierarchical multiple regression for hypothesis 2 
 
Model Β SE (B) Beta t 
1. Constant 191.240 33.491  5.710 
Total SAQ  .516 .095 .539*** 5.436 
2. Constant 367.137 71.215  5.155 
Total SAQ  .443 .106 .463*** 4.182 
Total PHQ score -2.286 1.432 -.189 -1.596 
Age -19.449 6.429 -.304** -3.025 
Gender -4.898 18.480 -.026 -.265 
BMI -1.837 1.630 -.118 -1.127 
Support available -.630 6.655 -.009 -.095 
3. Constant 405.238 77.543  5.226 
Total SAQ  .461 .107 .482*** 4.328 
Total PHQ score -.572 2.004 -.047 -.285 
Age -20.820 6.504 -.325** -3.201 
Gender -1.663 18.604 -.009 -.089 
BMI -1.842 1.625 -.119 -1.134 
 Social support  -2.798 6.866 -.041 -.408 
Total RRS Score -1.073 .881 -.188 -1.219 
Note. Depression (PHQ), cardiac QoL (SAQ), rumination measure (RRS) and 
body mass index (BMI). Adjusted R2  = .281 for step 1, R2  = .399 for step 2, ∆ 
R2 = .005 for step 3 (p> .05). * p < .05, ** p < .01, *** p < .001  
Hypothesis 3: RT (rumination) at baseline will predict QoL at three month follow-
up when controlling for depression, QoL, and cardiac QoL at baseline. 
Hypothesis 3 was also tested using a hierarchical multiple regression, 
with QoL (SF12) at follow-up, the dependent factor in this model.  Baseline QoL 
(SF12) was entered in the first step in the regression equation, baseline 
depression (PHQ), cardiac QoL at baseline and potential confounding variables 
of age, gender, BMI, and social support were added at step two, and RT (RRS) 
was added at step three.  The model met parametric assumptions as previously 
described and in line with Field (2013). 
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The overall model was significant, F(8, 75) = 18.375, p<.001. As 
expected, baseline QoL significantly predicted QoL three months later, 
accounting for 58% of the variance.  Contrary to the hypothesis, rumination at 
baseline did not significantly predict any additional variance after controlling for 
baseline depression, age, gender, BMI and social support, F(1, 67) = 2.468, p 
>.05.  Summary of the model can be seen in Table 8.  
Table 8. 
 
Results of hierarchical multiple regression for hypothesis 3 
 
Model B SE (B) Beta t
1. Constant 114.092 35.005  3.259 
Total SF12 .796 .077 .767*** 10.293 
2. Constant 410.642 125.826  3.264 
Total SF12 .480 .110 .463*** 4.381 
Total PHQ 
score 
-8.308 2.660 -.299** -3.123 
Age -25.321 11.232 -.169 -2.254 
Gender -.330 31.943 -.001 -.010 
BMI -3.509 2.772 -.099 -1.266 
Support 
available 
-7.617 11.255 -.048 -.677 
Total SAQ  .320 .206 .151 1.554 
3. Constant 494.442 135.438  3.651 
Total SF12 .475 .108 .458*** 4.376 
Total PHQ 
score 
-4.440 3.604 -.160 -1.232 
Age -27.831 11.227 -.186* -2.479 
Gender 6.535 31.904 .015 .205 
BMI -3.643 2.744 -.102 -1.328 
Support 
available 
-12.114 11.498 -.076 -1.054 
Total SAQ  .362 .205 .171 1.762 
Total 22 RRS  -2.558 1.628 -.180 -1.571 
Note. QoL (SF-12), Depression (PHQ), cardiac QoL (SAQ), rumination measure 
(RRS) and body mass index (BMI). Adjusted R2  = .583 for step 1, R2  = .642 for 
step 2, ∆ R2 = .008 for step 3 (p < .005). * p < .05, ** p < .01, *** p< .001  
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Discussion 
The aim of this study was to test whether RT (rumination) prospectively 
predicts symptoms of depression over a three month period in a CHD 
population.  As predicted, and consistent with previous comparable research 
(Denton et al., 2012), the results demonstrate that RT, specifically rumination, is 
a vulnerability factor for increased depression in CHD. Moreover, rumination at 
baseline is an independent and significant predictor of depression at a three 
month follow-up after controlling for baseline depression and other possible 
confounding factors.  The primary hypothesis was supported as the data 
showed a positive relationship in which increasing baseline rumination is 
associated with greater depression at three month follow-up.  This indicates that 
rumination may be a maintaining factor in severity of depression.   
The study supports the notion that rumination has a predictive effect on 
depression (Ciesla & Roberts, 2007; Nolen-Hoeksema et al., 2008).  Previous 
cross-sectional research has demonstrated a link between RT, depression and 
CHD (Dickens et al., 2012; Doyle et al., 2011a), which highlighted that RT could 
be a vulnerability factor for depression in CHD populations; the current study 
supports and extends this to a predictive prospective relationship.   
The findings of this study and Denton et al.’s (2012) study provide 
convergent evidence that rumination is a risk factor for increased or maintained 
depression in cardiac patients.  This extends the robust findings for rumination 
as a risk factor for depression in the general population (Nolen-Hoeksema, 
2000; Stafford et al., 2009) to a CHD population. The study aimed to replicate 
and extend the recent study by Denton et al. (2012) of an ACS population, 
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which found rumination brooding independently predicted depression severity at 
three month follow-up, explaining 1.2% of the variance.  The current study 
found that both the subscales of brooding and rumination independently 
predicted depression at three month-up follow up; 4% and 7% respectively.  
Additionally, when the full rumination measure (RRS) was applied it explained 
8.3% of the total variance of depression at three month follow-up when 
controlling for baseline depression and confounding variables. These results are 
consistent with the previous longitudinal research.  This study added to previous 
research (Denton et al., 2012) in its finding that both subscales of brooding and 
reflection predicted depression at three month follow-up, rather than just 
brooding as previously found, and with greater predictive variance than 
previously shown.    
The differences between the findings in the two studies should be noted 
and could be accounted for by methodological and analytic differences. Firstly, 
the current study controlled for a number of possible confounding factors 
revealed in the preliminary analyses (gender, age, BMI, and social support) 
which differed from Denton et al. (2012).  Secondly, different possible 
confounding variables were controlled for in the two studies: Denton et al. 
(2012) measured and controlled for psychosocial vulnerabilities, but  did not 
control for QoL and Cardiac QoL, which was significantly correlated with 
depression and rumination in the current data.  Some constructs were 
measured differently, including depression and cardiac severity, which may also 
account for some variance.  The Denton et al. (2012) study excluded 
participants with a BDI of 5-9, whereas the current study included all 
participants irrelevant of depression score at baseline, which arguably provided 
a more representative CHD sample.  The participant samples varied between 
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the two studies.  The current study was conducted in the UK which has a 
different healthcare system to the US and could have influenced participants, 
cardiac health, QoL and psychological wellbeing. The current study also 
recruited from a wider diagnostic category of CHD opposed to a specific 
diagnosis (ACS), this could explain some of the variation in the findings. 
Moreover, the current study recruited both inpatients and outpatients at varying 
stages of treatment and time since CHD diagnosis.  Although time since 
diagnosis was not a confounding factor, the flexibility in the recruitment process 
may have had an impact and delivered a more representative CHD sample. 
Lastly, there are differences between the current study and the Denton et al. 
(2012) findings for the rumination subscales (brooding and reflection).  The 
current study showed that both sub-scales of rumination are associated with 
depression, whereas Denton et al. (2012) only found that brooding was 
associated.  An example of a brooding thought that post-MI patients’ might have 
is ‘What have I done to deserve this?’.  Brooding is the more pathological 
component of rumination so it is more likely to be found in the more depressed 
patients.  However, in the current study reflection was also found to be 
predictive of depression over time. This is consistent with the wider literature, 
which finds that although brooding is more pathological, reflection can have 
pathological effects (Watkins, 2008).  It is also possible that the current study’s 
findings are within the confidence interval given that Denton et al.’s (2012) study 
had a much larger sample; this would support replication of the study to support 
the findings. 
The findings show that rumination plays an important role in predicting 
depression outcomes (Nolen-Hoeksema, 2000) and this study has extended 
this to a CHD population.  It supports the Nolen-Hoeksema (1991) Response 
80 
 
Style Theory, which proposed that a continued rumination response prolongs 
depression.  
The findings are not consistent with the Brosschot et al.’s (2006) model 
and it may be that more extensive and physiological assessment of cardiac 
health would have determined a relationship.  Furthermore in order to support a 
hypothesis that RT prolongs a stress response which worsens cardiac health 
and can contribute to the onset of cardiac problems, participants would have 
needed to have been assessed before and after cardiac events, which was not 
possible in the current study. The current study does however show RT is a 
factor involved in depression in patients with CHD. Larsen and Christenfeld’s 
(2009) theory which extends Brosschot et al.’s (2006) model to include 
depression is partially supported by the findings.  It has been shown that 
rumination extends and predicts depression in CHD and evidence has found 
rumination affects cardiac recovery (Verkuil et al., 2009).  Further research with 
accurate measurement of CHD symptoms is required to investigate this 
hypothesis fully; however, this study goes some way in identifying that 
rumination could play a role in the relationship between CHD and depression.   
The study also tested two secondary hypotheses, investigating if RT at 
baseline was predictive of QoL or cardiac QoL at three month follow-up when 
controlling for baseline QoL or cardiac QoL, baseline depression, and 
confounding factors.  However, despite overall significant models, both 
secondary hypotheses were unsupported and rumination was not an 
independent predictor of QoL.  Although QoL and HRQoL have been found to 
be associated with depression in cardiac populations (Ruo et al., 2003; 
Pragodpol and Ryan, 2013), the findings of this study are not consistent with the 
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hypothesis that rumination is predictive of general QoL or Cardiac QoL. 
Therefore these finding are not supportive of theories which propose that 
rumination maintains and prolongs cardiac symptoms (Larsen and Christenfeld, 
2009; Brosschot et al.’s, 2006). However, this could reflect the relatively low 
power of this sample given the sample size, or that the measures of cardiac 
symptoms are not that sensitive. The findings of this study only support an 
association between rumination and depression in CHD patients. 
The results of the current study have important clinical implications, in 
both medical and psychological settings.  In a medical setting it supports the 
notion that depression screening in cardiac populations is necessary to identify 
the 21% of cardiac patients with above moderate levels of depression and raise 
practitioners awareness of this (Larsen, Vestergaard, Søndergaard, & 
Christensen, 2013).  Identifying CHD patients with depression is important given 
the relationship between mortality in cardiac populations and depression (Barth 
et al., 2004; Dickens et al., 2008b).  If additional research found rumination to 
be a key mechanism then this could also be screened for so that those with 
elevated longitudinal risk could be identified.  Patients with high rumination 
scores would be at increased risk of depression; and beneficial psychological 
treatments could be rumination-focused cognitive-behavioural therapy (Watkins 
et al., 2011).  Specific psychological interventions for patients with CHD are 
recommended (Dickens et al., 2013); tailored and preventive treatments could 
potentially reduce levels of depression and concurrently improve cardiac 
outcomes.  Reducing the prevalence of depression in medical settings could be 
beneficial as patients with co-morbid major depression and a chronic illness 
have been found to cost between 50-100% more in primary care than non-
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depressed patients, despite socioeconomic status and the medical condition 
being controlled for (Katon, 2011).   
 
Limitations and recommendations for future directions 
There are several limitations to this study.  Firstly our assessment of 
depression, RT, QoL and cardiac QoL relied on self-report assessment.  Ideally 
depression would have been assessed via clinical interview and psychometric 
assessment which would have provided a more reliable diagnosis and risk 
assessment.  Additionally, for measurement of cardiac severity, rather than 
being categorised, it could have been assessed for via symptom checklists or 
biological measures.  However, the study did not have the capacity to complete 
this with the sample, and it may have served to reduce the number of willing 
participants.  Therefore, the PHQ-9 was chosen as a valid and reliable measure 
of the severity for depression (Kroenke et al., 2001).  It is widely used in medical 
settings (Gilbody et al., 2007) and for screening depression in CHD patients 
(Lichtman et al., 2008).  Cardiac severity was measured using the NYHA, a 
widely used categorisation; however, it resulted in the majority of participants 
being in one of two categories; a more precise measure would have been 
advantageous.  Secondly, in order to provide a robust analysis a large sample 
was required and subsequently it consisted of a broad range of diagnoses 
within CHD, e.g. a heterogenous sample.  Replication of the current research by 
dividing participants using their specific diagnosis (e.g. post-MI or ACS) could 
explore similarities and differences between this and previous comparable 
research (Denton et al, 2012).   
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Similarly to previous research in this area, 21% of participants were 
found to be suffering with above moderate depression (Dickens et al., 2004).  
The overall mean depression levels were mild and reduced to minimal at follow-
up, and there was also a reduction in rumination. This is indicative of a 
reduction in depression and rumination with the passing of time.  
To enable flexibility during recruitment, the participants recruited were 
both inpatients and outpatients which resulted in great variation of time since 
diagnosis. Time since diagnosis was not significantly correlated to any key 
variables. However, it could have influenced the level of rumination and 
depression participants experienced.  It is thought that depression after a 
cardiac event is dependent on pre-depression level and the severity of the 
cardiac event (Dickens et al., 2005).  Depression severity has also been found 
to be related to length of stay in hospital post-MI (Dickens, 2005).  Therefore the 
relationship between depression and CHD is complicated and duration in 
hospital and pre-diagnosis depression could be factors that would ideally be 
controlled for.  Participants recruited immediately post-MI could have increases 
in rumination because of the sudden life event, with rumination thought to be 
affected by more severe negative events (Moberly & Watkins, 2008). However, 
it could be argued that those recruited later, during cardiac rehabilitation, may 
have had more time to realise the impact of their cardiac condition and the 
reduced likelihood of attaining goals (Carver & Scheier, 1990), which may have 
increased rumination.  Further qualitative research could investigate specific 
ruminative cognitions and patients’ experience at different treatment points to 
contextualise the relationship between rumination and depression in a cardiac 
population.  
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The time-constraints surrounding the project meant only one three month 
follow-up period was attainable.  However, additional follow-up periods at six 
and twelve months could provide additional understanding of the longer term 
implications of rumination on depression in a CHD population.  Additional 
longitudinal data would have the potential to better investigate the impact of 
rumination on cardiac symptoms e.g. through future cardiac event, hospital 
admission or deaths.   
Participants’ historical information was not gathered so it is not known 
whether participants were receiving a psychological or medical intervention, if 
they were previously depressed or had a psychiatric history.  This could impact 
on levels of depression and rumination and could not be controlled for.  If this 
study was replicated it would be helpful to gather participants’ historical data at 
recruitment.   
A gap in the literature is also whether rumination or depression can 
predict the onset of CHD or if they are a consequence of CHD.  A larger cohort 
study that recruited participants’ pre-CHD could explore this in more detail.  In 
line with best practice, a randomised controlled trial of psychological 
interventions for cardiac patients could be beneficial to develop an evidence-
based treatment for depression in cardiac populations (Davidson, Rieckmann, & 
Lesperance, 2004). 
Given the findings in this study show that the overall mean population 
had mild depression, the results can only be applied generally to patients with 
CHD rather than to those with clinical depression.  There is limited comparable 
research, as such additional investigation is needed to support these findings.  
Additionally, further prospective longitudinal research that is more medically 
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focused could explore the effects of rumination on physiological changes, over-
time, on mortality (Larsen & Christenfeld, 2009) and how this relates to 
depression. 
Conclusion 
In conclusion, the results of the study contribute to a growing body of 
literature exploring potential mechanisms that link CHD and depression 
together.  To our knowledge this is the second study that has examined whether 
rumination is involved in the development of depressive symptoms in CHD 
patients using a prospectively longitudinal methodology, and the first of such 
studies to be conducted in the UK.  The findings of this study support previous 
research that demonstrated the relationship between depression and RT, but 
the study has extended this finding to a CHD population.  Due to the limited 
nature of research investigating RT in CHD and depression, the findings should 
be interpreted with caution but importantly should provide a foundation for 
further research.   
What is still unknown is whether rumination not only has an impact on 
depression but also on cardiac outcomes by affecting physiological systems. 
Future research may be able to substantiate a hypothesis of rumination 
mediating both psychological as well as physiological outcomes. 
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Appendix A: Glossary of Terms 
Counterfactual thinking- imagined mental representations of alternative 
versions of the past that would have improved the outcome now i.e. “if I had 
only …”  
Defensive pessimism- this is when people set low expectations about the 
future and reflect on and rehearse possible situations to plan what might 
happen or go wrong and then how it could be prevented. 
Depressive rumination- this is when people ruminate and think over their 
depressive symptoms.    
Emotional and cognitive processing- this is when people actively thinking 
about a stressor, and thinking about it implications.  
Habitual negative self-thinking- this is when people negative thinking has 
become like a habit and almost not conscious.   
Reflection-this is chronic self-consciousness, it includes exploring unique, or 
alternative self-perception. 
Perseverative cognition- it is thought of a key feature in worry and rumination.  
Brosschot (2006) model suggested repeated cognitions about a stress prolong 
the psychological problem or stressor and also prolong physiological responses.  
This prolonged stress response can then go onto to development disease i.e. 
cardiovascular.   
Planning, problem solving and mental stimulation- this is using cognitive 
coping strategies, such as anticipatory coping, planning, rehearsal, and problem 
solving. 
Positive rumination- this looks at how much somebody ruminates on positive 
emotions such as ‘happiness’. 
Post-event rumination- people ruminate about past events, this could be what 
happened or what they did or said.  
Worry- people think about the future and things they are uncertain about, 
people often try and problem solve future events such as catastrophes, risks 
and unseen events. 
Adapted from Watkins et al. (2003). 
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Appendix B- Participant pack 
  
 
A Prospective Longitudinal Study Repetitive Thought as a Vulnerability 
Factor for Depression in Coronary Heart Disease (CHD) Sufferers  
Participant Information Sheet 
I would like to invite you to take part in my research. My name is Laura Baker and I am a 
Trainee Clinical Psychologist with the University of Exeter.  I am conducting research at the 
Royal Devon and Exeter Trust.  My research hopes to understand the link between Coronary 
Heart Disease and depression.  
Before deciding whether or not you would like to participate, it is important for you to understand 
why the research is being done and what it will involve. Please take time to read the following 
information carefully.  
Please feel free to contact me directly (contact details are given below) if there is anything that 
is not clear, or if you would like more information. It is important that you understand that you do 
not have to take part in the research and that if you do agree to participate you are free to 
withdraw at any time without having to give a reason.   
Thank you for taking the time to read this. 
Summary of the study 
This study aims to look at the link between depression and Coronary Heart Disease.  It is 
particularly interested in understanding if there are particular thinking patterns linking together 
depression and Coronary Heart Disease.  If you agree to participate, you will be asked to fill out 
questionnaires which will take appropriately 20-30 minutes.  You will then be asked to fill out the 
same questionnaires again 3 months later.  The questionnaires will then either be posted to 
Rebecca Chawner (Cardiology Nurse Specialist) at the Royal Devon and Exeter Hospital with 
the provided stamped addressed envelope, or you will be able to complete them on-line.  I am 
hoping to recruit 110 participants for my study. The study has been reviewed and passed by the 
National Research Ethics Service (NRES) Committee South West- Exeter and by the Royal 
Devon and Exeter Trust research and development department. 
What is the purpose of the study? 
We know that people with Coronary Heart Disease are more likely to suffer with depression.  
However it is not known if depression increases the likelihood of somebody suffering with 
Coronary Heart Disease or if suffering with Coronary Heart Disease increases people’s 
likelihood of suffering with depression.  In order to understand this relationship, it is important to 
think about mechanisms that could be linking them together.  This research investigates if 
cognitive mechanisms such as repetitive thoughts (rumination and worry) might be involved in 
this link.  The study includes a 3 month follow-up as this will provide information about whether 
the way people with Coronary Heart Disease think has an impact on Coronary Heart Disease 
and depression over time.   
Why have I been invited? 
You have been chosen because you have a diagnosis of Coronary Heart Disease. 
Do I have to take part? 
It is completely up to you whether or not to take part.  If you do decide to take part, please sign 
and return the ‘consent to contact’ sheet which is enclosed with this pack or contact me (with 
the details below).  I will then contact you, to arrange sending you a questionnaire pack by your 
chosen method (post, email or on-line survey). If you decide you would like to take part, you are 
still free to withdraw at anytime without giving a reason.   
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If you are unsure about taking part you may find it helpful to discuss your decision with other 
people such as friends, family or your GP.  
What will happen to me if I take part?  
If you decide to take part in the study it will involve filling out one questionnaire pack when you 
join the study and filling out a second one 3 months later.  Each pack will take approximately 
20-30 minutes.   We will agree your preferred method to send you the second questionnaire 
(on-line survey, email, post).  If the questionnaire has not been returned after two weeks then I 
will contact you to offer a polite reminder. I will agree your preferred reminder method (phone, 
text, email, post) with you in advance. You will be given a copy of this information sheet and a 
signed copy of your consent form to keep.  We will also inform your GP of your participation by 
letter.  If I realise that you do not meet the criteria for the study then I will withdraw your 
participation.   
In some cases, to gather all of the information that I am hoping to collect I may need to access 
medical records.  I will ask for your consent to this and I have been given permission to access 
medical records by Royal Devon and Exeter Trust.  If you wish for your records not to be 
accessed that is fine and you can still take part in the study.  
What do I have to do in order to take part? 
If you received this information sheet from your Cardiac Nurse and you would like to take part, 
please sign and return the ‘consent to contact’ sheet in the stamped addressed envelope.  I will 
then contact you, to arrange sending you a questionnaire pack by your chosen method (post, 
email or on-line survey). 
If you are reading this information already with the questionnaire pack then, please fill in the 
‘consent to contact’ sheet and ‘participant consent’ sheet.  Then please fill in the questionnaires 
enclosed in the pack and return them with the consent forms, in the stamped addressed 
envelope.  You will be informed when I have received your questionnaires and arrange how to 
send your second pack 3 months later.  It is important for you to be assured that all information 
will be treated confidentially and all data will be anonymous.   
What are the possible disadvantages and risks of taking part? 
The questionnaires measure depression, worry, and rumination.  Some of the questions may be 
difficult and you may find them upsetting.  Information about support services available are 
listed below.  
What are the possible benefits of taking part? 
It is hoped that the information gathered in this study may help to provide more information 
about the link between Coronary Heart Disease and depression, and that this will contribute to 
better screening, treatment and interventions for depression in patients with Coronary Heart 
Disease.   
What would happen if we were concerned about your safety? 
When you join the study a letter will be sent to your GP informing them of your participation and 
giving them a brief outline of the study. One of the questionnaires you will complete may show 
that you may be suffering from depression.  If this were to happen, I would take appropriate 
steps to ensure your wellbeing.  I would inform your cardiologist and GP, by letter or telephone 
call.   
What if there is a problem? 
Any complaint about the way you have been dealt with during the study will be addressed. 
Complaints should be in relation to adverse effects from the study and not about your treatment 
by the Cardiology Unit, which instead should be addressed with the Royal Devon and Exeter 
Trust.  If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions 07581 048672.  If you remain 
unhappy and wish to complain formally, you can do this through the NHS Complaints 
Procedure.  Details can be obtained from 
http://www.nhs.uk/choiceintheNHS/Rightsandpledges/complaints.  
In the very unlikely event that something does go wrong and you are harmed during the 
research and this is due to someone‘s negligence then you may have grounds for a legal action 
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for compensation against the University of Exeter, but you may have to pay your legal costs. 
The normal National Health Service complaints mechanisms will still be available to you. 
Will my taking part in this study be kept confidential? 
Data will be kept confidential.  Your responses from the questionnaire will be anonymised and 
you will be assigned a number code.  Personal information will be stored separately to the raw 
data.  I will be the only person that has access to this and it will be securely stored in a 
password protected database.  Personal data will not be kept once the study has been 
completed. It is only required so that I can contact you to collect the second set of data and 
disseminate the study’s results.  Data will be securely stored in a locked filing cabinet and 
electronic data will be password protected.  Anonymised raw data from the study may be stored 
for up to five years.  If you decide you would like to withdraw from the study your data will be 
destroyed.  Your GP will be informed of your participation in the study. 
What will happen to results of the study? 
I am hoping to publish the study in an academic journal; no identifiable information will be 
included. Results of the research will be sent to all participants. 
Who is organising and funding the research? 
I am a paid employee of the NHS. I am completing my doctorate in Clinical Psychology at the 
University of Exeter, which has been funded by the NHS.  This study is being conducted as part 
of my academic qualification and I do not receive any additional funding or payment for carrying 
it out.  My research is being supervised by Professor Edward Watkins and Professor Chris 
Dickens who are employed by the University of Exeter. 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people called a Research 
Ethics Committee to protect your safety, rights, wellbeing and dignity.  This study has been 
reviewed and given favourable opinion by NRES committee South West- Exeter. 
Further information and contact details 
If you would like any advice about participating in research you can contact Consumers for 
Ethics in Research (CERES), this is an organisation that offers information and advice on 
research in the NHS. CERES, PO Box 1365, London, N16 0BW Email: info@ceres.org.uk 
Visit: http://www.ceres.org.uk/about.htm 
Support services available:  
• The Samaritans, website: http://www.samaritans.org, helpline: 08457 90 90 90 
• British Heart Foundation, website: www.bhf.org.uk, heart helpline: 0300 330 3311 
• NHS Choices website www.bhf.org.uk provides information and guidance of heart 
disease  
If you have any further questions please feel free to talk to Laura Baker, the study’s Chief 
Investigator.  Address: The Cardiology Department, Royal Devon & Exeter NHS Foundation 
Trust, Barrack Road, Exeter, EX2 5DW.  
Tel: 07581 048672  Email: chdresearchexeter@gmail.com  
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A Prospective Longitudinal Study Repetitive Thought as a Vulnerability 
Factor for Depression in Coronary Heart Disease (CHD) Sufferers 
Consent Form 
Name of Researcher: Laura Baker 
Patient Identification Number for this trial: 
Please initial 
all boxes  
1. I confirm that I have read and understand the information sheet 
dated April 2013 (Version 2) for the above study.  I have had the 
opportunity to consider the information, ask questions and have had 
these answered satisfactorily. 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my medical 
treatment being affected. 
3. I understand that relevant sections of my medical notes and data 
collected during the study may be looked at by individuals from the 
University of Exeter, from regulatory authorities or from the NHS 
Trust, where it is relevant to my taking part in this research.  I give 
permission for these individuals to have access to my records. 
4. I understand that my personal details will be kept secure place and 
any information that is entered onto a computer will be password 
protected.  There will be no identifiable details used in the research 
write-up and/or publication. 
5. I agree to my GP being informed of my participation in the study.   
  
6. I agree that the researchers may contact me to remind me to return 
my questionniares after two weeks if they have not been received.  
The research will contact me by an agreed method (phone, text, 
email, post).   
7. I agree to take part in the above study. 
            
Name of Participant  Date    Signature                               
            
Name of Person   Date    Signature  
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taking consent.  
  
 
A Prospective Longitudinal Study Repetitive Thought as a Vulnerability 
Factor for Depression in Coronary Heart Disease (CHD) Sufferers 
Consent to Contact Sheet 
1. I have read and understand the information sheet provided. 
2. I consent to be contacted by Laura Baker to discuss the possibility of 
taking part in the above research. 
3. I understand I can contact Laura Baker to discuss any aspect of the 
research before taking part and I am not committed to take part until I 
decide to. 
4. I am aware that I have the right to withdraw from the study at any time. 
5. I understand that participation in the study will not affect my cardiac 
treatment or any other treatment I receive in anyway. 
 
 
Name: …………………………………………………………….. 
Contact details: 
Address: ……………………………………………………………. 
……………………………………………………………………… 
……………………………………………………………………… 
Telephone no: ……………………………………………………….. 
Mobile no: …………………………………………………………… 
Email: ……………………………………………………………….. 
Preferred contact type (telephone, text, email, post): 
…………………………………………………………… 
Signature: …………………………………………………………… 
Date: …………………………………………………………… 
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A Prospective Longitudinal Study Repetitive Thought as a Vulnerability 
Factor for Depression in Coronary Heart Disease (CHD) Sufferers  
 
Participant Questionnaire 
 
Please complete as many of the questions below as you feel comfortable to do 
so, please tick where appropriate.  This information will be kept anonymous 
and confidential. 
 
 
Name …………………………………………….. 
 
Address………………………………………………………………………………… 
 
…………………………………………………………………… 
 
Contact Number ………………………………………… 
 
GP Surgery……………………………………..  GP Name  
 
……………………………. 
 
 
Age:   18-25    26-35    36-45   46-55   
  56-65    66-75   76-85   85 and over 
 
Sex :              Male                 Female   
 
 
Employment status: 
 
 
 
 
 
Employed full-time (30 hours or more per week)  
 
Employed Part-time  
 
Unemployed  
 
Full-time student  
 
Retired  
 
Full-time homemaker or carer  
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Ethnicity:  
 
 
Marital status: 
 
Smoking status: 
 
 
 
 
 
 
 
White 
  British 
  Irish 
  Any other White background 
Mixed 
  White and Black Caribbean 
  White and Black African 
  White and Asian 
  Any other mixed background 
Asian or Asian British 
  Indian 
  Pakistani 
  Bangladeshi 
  Any other Asian background 
Black or British Black 
  Caribbean 
  African 
  Any other Black background 
Other ethnic groups 
  Chinese 
  Any other ethnic group 
Not stated 
   
 
Married 
 
 
Single 
 
 
Co-habiting 
 
 
Civil union 
 
 
Widowed 
 
 
Divorced 
 
 
Never smoked 
 
 
Former smoker 
 
 
Current smoker * 
 
*If you are a current smoker, please state how many 
cigarettes on average you smoke per week  
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Alcohol consumption:  
 
Exercise: 
 
How many fruit and vegetables to you consume each day ……. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Do you drink alcohol? Yes      No  
If Yes how many units did you drink in the 
past week? ……… 
(see guide below) 
Pint of large/beer/cider – 3 units 
Small glass of wine (125ml)- 1.5 
Bottle of wine (750ml)- 10 units 
Single sprit mixer- 1 unit 
Do you exercise? Yes      No  If Yes, please state how many hours for each 
type of exercise you completed in the last 
week? 
 
Mild Exercise (e.g. walking) …… 
Moderate Exercise (e.g. fast walking, cycling, 
swimming, playing tennis)  …….. 
Vigorous Exercise (e.g. running/jogging, fast 
swimming, aerobics)  …….. 
 
Do you suffer from any other 
health conditions? 
Yes      No  
 
If Yes please state which conditions 
………………………………………................. 
………………………………………………….. 
……………………………………………………..
Do you suffer from diabetes: Please Tick 
one box 
No 
 
 
Yes- Type 1 Diabetes 
 
 
Yes- Type 2 Diabetes 
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What is your weight? Stone….. Pounds….. or …….. KG 
What is your height? Feet……  Inches…… or Meters …….Centimetres.. 
When were you diagnosed with Coronary Heart Disease?  __/__/__  
How many acute cardiac events have you had? …….. 
When was your last acute cardiac event?  …… 
 
Social Support 
 
Is there someone available to whom you can count on to listen to you when 
you need to talk?: (please tick one below) 
None of the time             
A little of the time            
Some of the time            
Most of the time              
All of the time                  
 
 
 
  
Are you currently married or living with a partner? Yes      No  
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PHQ9 
Over the last 2 weeks, how often have you been bothered by any of the 
following problems? 
 
 
 
Not at 
all 
Several 
days 
More 
than 
half 
Nearly 
every 
day 
1. Little interest or pleasure in doing things 
 
    
2. Feeling down, depressed, or hopeless 
 
    
3. Trouble falling asleep, staying asleep , OR 
sleeping too much 
 
    
4. Feeling tired or having little energy 
 
    
5. Poor appetite OR overeating 
 
    
6. Feeling bad about yourself OR feeling that you 
are a failure OR have let yourself or your family 
down 
 
    
7. Trouble concentrating on things such as 
reading a newspaper or watching television 
 
    
8. Moving or speaking so slowly that other people 
could have noticed Or the opposite, being so 
fidgety or restless that you have been moving 
around a lot more than usual 
 
    
9. Thoughts  that you would be better off dead or 
thoughts of hurting yourself in some way 
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PSWQ 
Rate each of the following statements on a scale of 1 (‘not at all typical of me’) 
to 5 (‘very typical of me’). Please do not leave any items blank. 
 
Not at all typical of me  1 2 3 4 5   Very typical of me 
 
1. If I do not have enough time to do 
everything, I do not worry about it 
1 2 3 4 5 
2. My worries overwhelm me 1 2 3 4 5 
3. I do not tend to worry about things 1 2 3 4 5 
4. Many situations make me worry 1 2 3 4 5 
5. I know I should not worry about things, 
but I just cannot help it 
1 2 3 4 5 
6. When I am under pressure I worry a lot 1 2 3 4 5 
7. I am always worrying about something 1 2 3 4 5 
8. I find it easy to dismiss worrisome 
thoughts 
1 2 3 4 5 
9. As soon as I finish one task, I start to 
worry about everything else I have to do 
1 2 3 4 5 
10. I never worry about anything 1 2 3 4 5 
11. When there is nothing more I can do 
about a concern, I do not worry about it 
anymore 
1 2 3 4 5 
12. I have been a worrier all my life 1 2 3 4 5 
13. I notice that I have been worrying about 
things 
1 2 3 4 5 
14. Once I start worrying , I cannot stop 1 2 3 4 5 
15. I worry all the time 1 2 3 4 5 
16. I worry about projects until they are done 1 2 3 4 5 
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Responses to Depression (RSQ) 
 
People think and do many different things when they feel down, sad or 
depressed. Please read each of the items below and indicate whether you 
never, sometimes, often, or always think or do each one when you feel down, 
sad or depressed. Please indicate what you generally do, not what you think 
you should do. 
 
Almost             Almost  
Never      Sometimes      Often      Always 
 
1. Think about how alone you feel. 
 
2. Think “I won’t be able to do my 
job/work because I feel so bad” 
 
3. Think about your feelings of fatigue 
and achiness 
 
4. Think about how hard it is to 
concentrate 
 
5. Think about how passive and 
unmotivated you feel 
 
6. Analyse recent events to try and 
understand why you are depressed. 
 
7. Think about how you don’t seem to 
feel anything anymore 
 
8. Think “Why can’t I get going?” 
 
9. Think “Why do I always react this 
way?” 
 
10. Go away by yourself and think 
about why you feel this way 
 
11. Write down what you are thinking 
about and analyse it 
 
12. Think about a recent situation, 
wishing it would have gone better 
 
13. Think “Why do I have problems 
other people don’t have?” 
 
14. Think about how sad you feel 
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Almost             Almost  
Never      Sometimes      Often      Always 
 
15. Think about all your shortcomings, 
failings, faults and mistakes 
 
16. Think about how you don’t feel up 
to doing anything 
 
17. Analyse your personality to try and 
understand why you are depressed 
 
18. Go someplace alone to think about 
your feelings 
 
19. Think about how angry you are with 
yourself 
 
20. Listen to sad music 
 
21. Isolate yourself and think about the 
reasons why you feel sad 
 
22. Try to understand yourself by 
focusing on your depressed mood 
 
23. Think “What am I doing to deserve 
this?” 
 
24. Think “I won’t be able to 
concentrate if I keep feeling this 
way”.  
 
25. Think “Why can’t I handle things 
better?” 
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The Seattle Angina Questionnaire 
1. The following is a list of activities that people often do during the week. Although for 
some people with several medical problems it is difficult to determine what it is that 
limits them, please go over the activities listed below and indicate how much limitation 
you have had due to chest pain, chest tightness, or angina over the past 4 weeks. 
If you do not suffer from angina then please relate the responses to your specific 
problems. 
Activity Extremely Limited 
Quite a 
bit 
Limited 
Moderately 
Limited 
Slightly 
Limited 
Not at 
all 
Limited 
Limited for 
other 
reasons or 
did not do 
the activity 
Dressing yourself  
      
Walking indoors 
on level ground        
Showering  
      
Climbing a hill or a 
flight of stairs 
without stopping        
Gardening, 
vacuuming, or 
carrying groceries        
Walking more than 
a block at a brisk 
pace        
Running or jogging 
      
Lifting or moving 
heavy objects (e.g. 
furniture, children)        
Participating in 
strenuous sports 
(e.g.swimming, 
tennis)  
      
 
2. Compared with 4 weeks ago, how often do you have chest pain, chest tightness, 
or angina when doing your most strenuous activities? 
 
I have had chest pain, chest tightness, or angina...  
Much 
more often 
Slightly 
more often 
About the 
same 
Slightly 
less often 
Much 
less often 
I have had no chest 
pain over the last 4 
weeks 
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3. Over the past 4 weeks, on average, how many times have you had chest pain, 
chest tightness, or angina? 
 
I have had chest pain, chest tightness, or angina...  
4 or more 
times per 
day 
1-3 times 
per day 
3 or more times per 
week but not every 
day 
1-2 times 
per week 
Less than 
once a week 
None over the 
past 4 weeks 
      
 
4. Over the past 4 weeks, on average, how many times have you had to take 
nitroglycerin (nitroglycerin tablets or spray) for your chest pain, chest tightness, or 
angina? 
 
I have taken nitroglycerin...  
4 or more 
times per 
day 
1-3 times 
per day 
3 or more times per 
week but not every 
day 
1-2 times 
per week 
Less than 
once a week 
None over the 
past 4 weeks 
      
 
5. How bothersome is it for you to take your pills for chest pain, chest tightness, or 
angina as prescribed?  
Extremely 
bothersome 
Quite a bit 
bothersome 
Moderately 
bothersome 
Slightly 
bothersome 
Not 
bothersome 
at all 
My doctor has 
not 
prescribed 
pills 
      
 
6. How satisfied are you that everything possible is being done to treat your chest 
pain, chest tightness, or angina?  
Not satisfied at 
all 
Mostly 
dissatisfied 
Somewhat 
satisfied 
Mostly 
satisfied 
Completely 
satisfied 
     
 
7. How satisfied are you with the explanations your doctor has given you about your 
chest pain, chest tightness, or angina?  
Not satisfied at 
all 
Mostly 
dissatisfied 
Somewhat 
satisfied 
Mostly 
satisfied 
Completely 
satisfied 
     
 
8. Overall, how satisfied are you with the current treatment of your chest pain, chest 
tightness, or angina?  
Not satisfied at 
all 
Mostly 
dissatisfied 
Somewhat 
satisfied 
Mostly 
satisfied 
Completely 
satisfied 
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9. Over the past 4 weeks, how much has your chest pain, chest tightness, or angina 
limited your enjoyment of life?  
It has extremely 
limited my 
enjoyment of life 
It has limited my 
enjoyment of life 
quite a bit 
It has moderately 
limited my 
enjoyment of life 
It has slightly 
limited my 
enjoyment of 
life 
It has not 
limited my 
enjoyment of life 
at all 
     
 
 
 
10. If you had to spend the rest of your life with your chest pain, chest tightness, or 
angina the way it is right now, how would you feel about this?  
Not satisfied at 
all 
Mostly 
dissatisfied 
Somewhat 
satisfied 
Mostly 
satisfied 
Completely 
satisfied 
     
 
 
11. How often do you think or worry that you may have a heart attack or die suddenly?  
I can't stop 
thinking or worrying 
about it 
I often think 
or worry 
about it 
I occasionally think 
or worry about it 
I rarely think 
or worry about 
it 
I never think 
or worry about 
it 
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SF-12 
This survey asks for your views about your health. This information will help you keep 
track of how you feel and how well you are able to do your usual activities. Thank you 
for completing this survey! 
For each of the following questions, please tick the circle that best describes 
your answer. 
 
1)  In general, would you say your health is:  
 
 
 
 
5)  During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework)?  
 
Excellent Very good Good Fair Poor 
     
2)  The following questions are about activities you might do during a typical day. Does 
your health now limit you in these activities? If so, how much? 
    
Yes, 
limited 
a lot 
Yes, 
limited 
a little 
No, not 
limited 
at all 
a. Moderate activities, such as moving a table, 
pushing a vacuum cleaner, bowling, or playing golf    
b. Climbing several flights of stairs 
   
 
3)  During the past 4 weeks, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of your physical 
health? 
    
All 
of the 
time 
Most 
of the 
time 
Some 
of the 
time 
A little 
of the 
time 
None 
of the 
time 
a. Accomplished less than you would 
like      
b. Were limited in the kind of work or 
other activities      
4)  During the past 4 weeks, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any emotional 
problems (such as feeling depressed or anxious)? 
  
  
All of 
the time 
Most of 
the time 
Some of 
the time 
A little 
of the 
time 
None of 
the time 
a. Accomplished less than you would 
like      
b. Did work or activities less carefully 
than usual      
Not at all A little bit Moderately Quite a bit Extremely 
     
6)  These questions are about how you feel and how things have been with you during 
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7)  During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting friends, relatives, 
etc.)?  
Thank you for filling in this questionnaire 
 
 
 
 
  
the past 4 weeks. For each question, please give the one answer that comes closest to 
the way you have been feeling. How much of the time during the past 4 weeks... 
    All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
a. Have you felt calm and 
peaceful?      
b. Did you have a lot of energy? 
     
c. Have you felt downhearted and 
depressed?      
All of the time Most of the time 
Some of the 
time 
A little of the 
time None of the time 
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Psychology Research Ethics 
Committee 
 
Psychology, College of Life & 
Environmental Sciences 
 
 
Washington Singer Laboratories 
Perry Road 
Exeter 
EX4 4QG 
 
Telephone +44 (0)1392 724611 
Fax +44 (0)1392 724623 
Email Marilyn.evans@exeter.ac.uk 
To: Laura Baker 
From: 
CC: 
Cris Burgess 
Ed Watkins & Chris Dickens 
Re: Application 2012/546 to Ethics Committee 
Date: 11 August 2014 
 
The School of Psychology Ethics Committee met on recently and your proposal 
was discussed. The Committee raised a number of conditions of agreement to 
this application being accepted. You would be expected to address these before 
beginning the research but sight of the evidence is not required by the 
Committee and the project has been approved in principle for the duration of 
your study. 
The conditions are as follows: 
 
• Management approval is sought and granted for each NHS/non-NHS 
host organisation involved in the research. 
 
In any correspondence with the Ethics Committee about this application, please 
quote the reference number above or decisions may be delayed. 
Yours sincerely,  
 
Cris Burgess 
Chair of School Ethics Committee 
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Appendix D- Extended Results 
 
Power Analysis. A priori power calculation was determined using G* 
Power 3.1 software (Faul, Erdfelder, Lang, & Buchner, 2007)(Faul et al., 2007).  
The regression calculation was based on the assumption that up to four 
variables may need to be controlled for following the correlation. It allowed for 
one tested predictor and up to eight total predictors, for 95% power, with a 
medium effect size of 0.15, alpha of 0.05, 89 participants were required.  In a 
comparable study, Denton (2012), they had 387 participants with significance 
<0.001.  The crosslagged correlation between rumination and depression was 
0.49, indicating a large effect size. On this basis, the current study is suitably 
powered.   
Extended Data Management. 
Missing data. In order to utilise all participants data, participants were 
still included if they had missing data on a specific measure but they would not 
be included in any analysis which required that measure. If participants 
measures could not be scored due to missing data the entry was set as missing 
data.  Descriptive data of all variables was examined to ensure all data was 
within expected ranges, means and SD.  
Tests of normality and outliers. Boxplots were used to identify and 
explore outliers. Histograms were created for the continuous key variables and 
visually examined for skewness and kurtosis. Skewness and kurtosis were also 
calculated and converted to z-scores (standard residuals) as recommended by 
Field (2013) to ensure 99% of z scores were within the range of -3.29 and 
+3.29. Z scores outside of this range indicated participants’ variables were 
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significantly different from normal distribution.  This was the case for measures 
of baseline and follow-up depression and rumination (see below).   
 
Figure D 1. Box-plot to show outliers on measure of depression at baseline. 
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Figure D 2. Box-plot to show outliers on measure of depression at follow-up. 
 
Figure D 3. Box-plot to show outliers on measure of rumination at baseline. 
 
Figure D 4. Box-plot to show outliers on measure of rumination at follow-up. 
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Parametric assumptions of the regression were checked prior to 
evaluation of the model as suggested by Field (2013).  Multicollinearity was 
checked by looking at the correlation table to ensure that predicator variables 
did not correlate above .90 and checking variance inflation factor (VIF) was 
close to one.  Durbin-Watson was checked to examine independence of the 
residuals and ensuring values were between one and three. 
Histograms and P-Plots were used to examine normality or the residuals, 
with no major deviations apparent.  Mahalalanobis distance measures the 
extent to which cases are multivariate outliers, and should not exceed the 
critical value for the number of predictors in each analysis (Barnett, 1978); this 
assumption was met with all data.  Casewise diagnostics showed only 1% of 
cases were identified, which is below what would be expected for this model.  
Cooks distance measures the overall influence of one case on the model as this 
was below one in all cases, it suggests the model is predictive despite any 
outliers. 
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Appendix F: Dissemination statement 
The results of this study will be disseminated to interested parties 
through feedback, journal publication and presentation.  
Dissemination to participants and NHS services.  
As stated on the participant information sheet participants will be informed of 
the results of the study. Participants will be provided with details of who to 
contact, should they require further information.  Additionally the cardiac staff 
involved in the research will be provided with a summary of the findings. The 
NHS research ethics committee at Exeter and RD&E Research and 
Development team will be sent a summary of the findings of the study and will 
be informed that the study is now complete.  
Journal Publication  
It is expected that the study will be submitted for publication with the Journal of 
Psychosomatic Research (Impact factor 3.37). 
Presentation  
On 9th June 2014, my research findings were presented to an academic 
audience, for peer review, as part of the Doctorate in Clinical Psychology at the 
University of Exeter.  
The findings will also be orally presented to the Lifetime service in Bath, a 
specialist paediatric service which work closely with children and young people 
with complex cardiac conditions. 
